Globus Medical
Buy, Hold or Sell?

Let's analyse Globus Medical together

Penke I guess you are interested in Globus Medical. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Globus Medical. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Globus Medical

I send you an email if I find something interesting about Globus Medical.

Quick analysis of Globus Medical (30 sec.)

What can you expect buying and holding a share of Globus Medical? (30 sec.)

How much money do you get?

$0.00

When do you have the money?

1 year

How often do you get paid?

0.0%

What is your share worth?

Current worth

$28.76

Expected worth in 1 year

$41.17

How sure are you?

90.0%

+ What do you gain per year?

Total Gains per Share

$12.41

Return On Investment

24.6%

For what price can you sell your share?

Current Price per Share

$50.35

Expected price per share

$43.39 - $54.04

How sure are you?

50%

1. Valuation of Globus Medical (5 min.)

Live pricePrice per Share (EOD)

$50.35

Book Value per Share

$28.76

Intrinsic Value Per Share

$8.10 - $17.86

Total Value Per Share

$36.86 - $46.61

My calculation of the intrinsic value of Globus Medical is based how much money is coming from the company's main activities (Free Cash Flow).

The following numbers are based on moving averages and per share and per quarter.
I use a 6% discount rate for the low estimation and 3% for the high estimation.
The current Free Cash Flow Per Share is 10Y: ($0.26) 3Y: ($0.35) TTM: ($0.33)
The change per quarter (trend) of the Free Cash Flow Per Share is 10Y: ($0.01) 3Y: ($0.00) TTM: ($0.05)

Years	Total Low est.	Total High est.	Added Free Cash Flow
1	$1.02	$1.46	$1.06 - $1.53
2	$1.99	$3.00	$1.07 - $1.67
3	$2.91	$4.63	$1.07 - $1.81
4	$3.78	$6.33	$1.07 - $1.95
5	$4.60	$8.11	$1.08 - $2.09
6	$5.38	$9.95	$1.08 - $2.22
7	$6.12	$11.85	$1.09 - $2.36
8	$6.82	$13.80	$1.09 - $2.50
9	$7.48	$15.81	$1.09 - $2.64
10	$8.10	$17.86	$1.10 - $2.78

2. Growth of Globus Medical (5 min.)

Is Globus Medical growing?

	Current year	Previous year	Grow	Grow %
How rich?	$3.9b	$1.7b	$1.2b	41.3%

How much money is Globus Medical making?

	Current year	Previous year	Grow	Grow %
Making money	$30.7m	$47.5m	-$16.8m	-54.8%
Net Profit Margin	10.1%	18.5%	-	-

How much money comes from the company's main activities?

Quarterly Yearly

3. Financial Health of Globus Medical (5 min.)

4. Comparing to competitors in the Medical Devices industry (5 min.)

Industry Rankings (Medical Devices)

Richest
#13 / 339

Most Revenue
#39 / 339

Most Profit
#38 / 339

Most Efficient
#58 / 339

What can you expect buying and holding a share of Globus Medical? (5 min.)

Welcome investor! Globus Medical's management wants to use your money to grow the business. In return you get a share of Globus Medical.

What can you expect buying and holding a share of Globus Medical?

First you should know what it really means to hold a share of Globus Medical. And how you can make/lose money.

Speculation

The Price per Share of Globus Medical is $50.35. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

The fundamentals: the financial health trends of Globus Medical.
The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Globus Medical, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $28.76. Based on the TTM, the Book Value Change Per Share is $3.10 per quarter. Based on the YOY, the Book Value Change Per Share is $0.23 per quarter.
You may receive quarterly/yearly dividend in the form of additional shares.
You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.

Based on historical numbers we can estimate the returns while holding a share of Globus Medical.

How much money are you going to get?

	MRQ		TTM		YOY		5Y		10Y
	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share
Usd Eps	0.11	0.2%	0.27	0.5%	0.42	0.8%	0.32	0.6%	0.29	0.6%
Usd Book Value Change Per Share	-7.58	-15.0%	3.10	6.2%	0.23	0.5%	0.91	1.8%	0.61	1.2%
Usd Dividend Per Share	0.00	0.0%	0.00	0.0%	0.00	0.0%	0.00	0.0%	0.00	0.0%
Usd Total Gains Per Share	-7.58	-15.0%	3.10	6.2%	0.23	0.5%	0.91	1.8%	0.61	1.2%
Usd Price Per Share	53.29	-	54.78	-	65.94	-	58.88	-	45.00	-
Price to Earnings Ratio	123.19	-	404.56	-	40.27	-	112.34	-	71.42	-
Price-to-Total Gains Ratio	-7.03	-	46.20	-	80.35	-	72.59	-	85.96	-
Price to Book Ratio	1.85	-	2.49	-	4.19	-	3.99	-	4.17	-
Price-to-Total Gains Ratio	-7.03	-	46.20	-	80.35	-	72.59	-	85.96	-

When do you get the money?

Usd Investment	$.00
Usd Price Per Share	50.35
Number of shares	19

Gains per Quarter	Trailing 12 Months	5 Year
Usd Dividend Per Share	0.00	0.00
Usd Book Value Change Per Share	3.10	0.91
Usd Total Gains Per Share	3.10	0.91
Gains per Quarter (19 shares)	58.95	17.35
Gains per Year (19 shares)	235.79	69.39

Years	Return on Investment (TTM)			Return on Investment (5Y)
	Dividend	Book Value gain	Total gains	Dividend	Book Value gain	Total gains
Broker costs	-	-	-10	-	-	-10
1	0	236	226	0	69	59
2	0	472	462	0	139	128
3	0	707	698	0	208	197
4	0	943	934	0	278	266
5	0	1179	1170	0	347	335
6	0	1415	1406	0	416	404
7	0	1651	1642	0	486	473
8	0	1886	1878	0	555	542
9	0	2122	2114	0	625	611
10	0	2358	2350	0	694	680

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %

	Trailing 12 Months				3Y				5 Year				10 Year				ALLTIME
				%				%				%				%				%
Earnings Per Share	4.0	0.0	0.0	100.0%	12.0	0.0	0.0	100.0%	19.0	1.0	0.0	95.0%	39.0	1.0	0.0	97.5%	52.0	1.0	0.0	98.1%
Book Value Change Per Share	3.0	1.0	0.0	75.0%	10.0	2.0	0.0	83.3%	16.0	4.0	0.0	80.0%	36.0	4.0	0.0	90.0%	46.0	4.0	3.0	86.8%
Dividend per Share	0.0	0.0	4.0	0.0%	0.0	0.0	12.0	0.0%	0.0	0.0	20.0	0.0%	0.0	0.0	40.0	0.0%	0.0	0.0	53.0	0.0%
Total Gains per Share	3.0	1.0	0.0	75.0%	10.0	2.0	0.0	83.3%	16.0	4.0	0.0	80.0%	36.0	4.0	0.0	90.0%	46.0	4.0	3.0	86.8%

Fundamentals of Globus Medical

About Globus Medical

https://www.globusmedical.com
Medical Devices
5000
2560 General Armistead Avenue, Audubon, PA, United States, 19403
Google Maps Bing Maps

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Fundamental data was last updated by Penke on 2024-04-04 14:44:02.

Financial Health

Profitability Details

	Compared to previous year	Compared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.

Operating Efficiency Details

	Compared to previous year	Compared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.

Liquidity Details

	Compared to previous year	Compared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.

Solvency Details

	Compared to previous year	Compared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details

	Compared to previous year	Compared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Globus Medical.

1.1. Profitability

1.1.1. Net Profit Margin

Measures how much net profit Globus Medical earns for each $1 of revenue.

Above 10% is considered healthy but always compare Globus Medical to the Medical Devices industry mean.
A Net Profit Margin of 2.4% means that $0.02 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Globus Medical:

The MRQ is 2.4%. The company is making a profit. +1
The TTM is 10.1%. The company is making a huge profit. +2

Trends

Current period		Compared to		+/-
MRQ	2.4%	TTM	10.1%	-7.6%
TTM	10.1%	YOY	18.5%	-8.5%
TTM	10.1%	5Y	15.0%	-4.9%
5Y	15.0%	10Y	17.2%	-2.3%

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	2.4%	-11.2%	+13.6%
TTM	10.1%	-19.6%	+29.7%
YOY	18.5%	-14.4%	+32.9%
5Y	15.0%	-21.3%	+36.3%
10Y	17.2%	-24.8%	+42.0%

Measures how much net profit Globus Medical earns for each $1 of revenue.

Revenue is the amount of profit Globus Medical generates before taxes and all other costs. For example, when you buy a cup of coffee it will cost you $3. The company does not earn $3 in profit but also has to pay various costs and taxes to create that cup of coffee. Let's assume the cost of creating a cup of coffee is $1.5.

The $3 you pay for a cup of coffee is called revenue.
The $1.5 that’s left over when all costs to create that cup of coffee (including taxes) are deduced from the revenue is called net profit.

The net profit margin looks at how much net profit Globus Medical earns for each $1 in revenue.

How to use net profit margin

Higher profit margin is better (more profit).
Above 10% is considered healthy but always compare Globus Medical to the Medical Devices industry mean.
Can be used to compare companies within the Medical Devices industry.

You typically want a high profit margin. This means that for each $1 in sales, Globus Medical makes more profit. This shows the investor how efficiently Globus Medical is operating in general and compared to other companies in the same industry. Globus Medical operates in the Medical Devices industry.

Why do investors use net profit margin in their analysis

It helps investors to determine the efficiency of Globus Medical. If profit margins remain low (compared to the Medical Devices industry mean) and there are no improvements to make in production costs or other areas that might be a warning sign. If profit margins are high that means the company has low overhead costs and is efficiently using its resources to generate profit.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Net Profit Margin of Globus Medical is 0.02. This means that Globus Medical earned $0.02 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Net Profit Margin of the Medical Devices industry is -11.2%.
What is the trend?
The trend is important because it shows you how Globus Medical is performing over time. The most recent quarter might be important if Globus Medical released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Globus Medical up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare Globus Medical with other companies in the same industry (Medical Devices).
Net profit margin should rise over the years.
Can be influenced when Globus Medical sells assets (profit will increase while costs remain the same).
It won’t show what part of Globus Medical is doing great or needs improvement (it only looks at total revenue and total net income).

How to calculate net profit margin

Net profit margin = net income / total revenue * 100%

Real example of Globus Medical

You need the following data to determine net profit margin:

Income statement from the period you want to calculate (for example, MRQ or TTM).

Net income MRQ Globus Medical = 15,034
Total revenue MRQ Globus Medical = 616,534
$15,034 / $616,534 = 0.02 or 2.4%

Higher is better

The higher the net profit margin, the more efficient the company is generating income. This helps investors to determine how the company is managing money. The net profit margin is an important indicator when diving into the financial health of a company. Overall, you want to see the net profit margin rising over the years. That means the company improved their production and made it more efficient (if possible).

You can use the net profit margin to compare companies within the same industry. If there are two companies where one is much bigger but the smaller one has a higher net profit margin, that means the smaller company is more efficiently using operational costs.

Important: Profit margins can be very different between industries. Companies with assembly lines or transports are much more prone to see shifting in prices for fuel, ingredients and maintenance compared to companies that only provide services. You should never compare net profit margin between different industries.

1.1.2. Return on Assets

Shows how efficient Globus Medical is using its assets to generate profit.

Above 5% is considered healthy but always compare Globus Medical to the Medical Devices industry mean.
0.3% Return on Assets means that Globus Medical generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Globus Medical:

The MRQ is 0.3%. Using its assets, the company is inefficient in making profit. -1
The TTM is 1.3%. Using its assets, the company is less efficient in making profit.

Trends

Current period		Compared to		+/-
MRQ	0.3%	TTM	1.3%	-1.0%
TTM	1.3%	YOY	2.4%	-1.1%
TTM	1.3%	5Y	2.0%	-0.7%
5Y	2.0%	10Y	2.6%	-0.6%

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	0.3%	-4.0%	+4.3%
TTM	1.3%	-4.5%	+5.8%
YOY	2.4%	-4.8%	+7.2%
5Y	2.0%	-4.0%	+6.0%
10Y	2.6%	-4.9%	+7.5%

Shows how efficient Globus Medical is using its assets to generate profit.

For a farm, a tractor is considered an asset. The tractor helps ploughing the land making it possible to plant and harvest crops. But the tractor might be old and needing maintenance all the time reducing its efficiency. Return on assets indicates how effectively the farm is using the tractor (and other assets that help the core business) to plough the land.

How to use return on assets

Higher is better.
Above 5% is considered healthy but always compare Globus Medical to the Medical Devices industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on assets in their analysis

Shows the investor how effectively Globus Medical is using its resources to generate profit. If the return on assets (0.3%) from Globus Medical are higher than the Medical Devices mean (-4.0%) that means Globus Medical is using its resources better than their competitors. If not, that means their competitors are more efficient in using their resources to generate profit.

An investor should always look at:

What is the current return on assets?
The current most recent quarter (MRQ) Return on Assets of Globus Medical is 0.3%. This means the company generated $0.00 for each $1 in assets.
How does it compare to the industry?
The mean MRQ Return on Assets of the Medical Devices industry is -4.0%.
What is the trend?
The trend is important because it shows you how Globus Medical is performing over time. The most recent quarter might be important if Globus Medical released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Globus Medical up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
If a company has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

How to calculate return on assets

Return on assets = net income / total assets * 100%

Real example Globus Medical

You need the following data to determine return on assets (ROA):

Income statement
Balance sheet

Net income MRQ (income statement) from Globus Medical = 15,034
Total assets MRQ (balance sheet) from Globus Medical = 5,086,083
15,034 / 5,086,083 = 0.00 or 0.3%

ROA is an important ratio as it will tell you how effectively Globus Medical is using its resources to generate profits. Example:

Bob and Kristin both sell ice cream in the summer. They both have an ice cream truck. The truck Bob owes cost him $20.000 and the truck Kristin owes cost her $1500. Over the summer, Bob earned $2000 and Kristin earned $200. To calculate the return on assets:

Bob: $2000 / $20.000 * 100% = 10%
Kristin: $200 / $1500 * 100% = 13.3%

This tells you Bob’s company is more valuable but Kristin's company is more efficient. Be aware that total assets can change over time. A transportation business will buy and sell trucks or planes all the time. Before using return on assets as a guideline, you have to know what the exact assets are. For a company that has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

1.1.3. Return on Equity

Shows how efficient Globus Medical is using its investors money to generate profit.

Above 15%-20% is considered healthy but always compare Globus Medical to the Medical Devices industry mean.
0.4% Return on Equity means Globus Medical generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Globus Medical:

The MRQ is 0.4%. Using its investors money, the company is inefficient in making profit. -1
The TTM is 1.5%. Using its investors money, the company is inefficient in making profit. -1

Trends

Current period		Compared to		+/-
MRQ	0.4%	TTM	1.5%	-1.1%
TTM	1.5%	YOY	2.7%	-1.2%
TTM	1.5%	5Y	2.2%	-0.8%
5Y	2.2%	10Y	2.9%	-0.7%

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	0.4%	-3.9%	+4.3%
TTM	1.5%	-5.6%	+7.1%
YOY	2.7%	-5.9%	+8.6%
5Y	2.2%	-6.1%	+8.3%
10Y	2.9%	-7.0%	+9.9%

Shows how efficient Globus Medical is using its investors money to generate profit.

A publicly traded company (any company that issues shares to the public) is owned by its shareholders. Return on equity calculates the amount of profit for every $1 the shareholders invested.

How to use return on equity

Higher is better.
Above 15%-20% is considered healthy but always compare Globus Medical to the Medical Devices industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on equity in their analysis

To find out the owners/management's attitude toward their company. You typically want the owners/management to invest in the company and focus on generating profit. If not enough profit is generated (compared to the Medical Devices industry mean), the company might not be investing their money efficiently.

The three steps every investor should look at:

What is the current return on equity?
The current most recent quarter (MRQ) Return on Equity of Globus Medical is 0.4%. This means Globus Medical generated $0.00 for each $1 the owners (shareholders) invested.
How does it compare to the industry?
The mean MRQ Return on Equity of the Medical Devices industry is -3.9%.
What is the trend?
The trend is important because it shows you how Globus Medical is performing over time. The most recent quarter might be important if Globus Medical released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Globus Medical up to 10 years back (depending if Globus Medical existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Does not include intangible assets (non physical assets like licences, computer software, etc.).
Stockholders equity and shareholders equity refer to the same thing.
Liabilities should not be more than three times return on equity.

How to calculate return on equity

Return on equity = net profit / shareholders equity * 100%

Real example of Globus Medical

You need the following data to determine ROE:

Income statement
Balance sheet
Net profit MRQ (income statement) Globus Medical = 15,034
Shareholders equity (balance sheet) MRQ Globus Medical = 3,997,959
15,034 / 3,997,959 = 0.00 or 0.4%

A negative shareholder equity is a warning sign. It means the company has more liabilities than assets. It might also mean that the owners did not invest enough money or they are taking money out of the business.

1.2. Operating Efficiency of Globus Medical.

1.2. Operating Efficiency

1.2.1. Operating Margin

Measures how efficient Globus Medical is operating .

Measures how much profit Globus Medical makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
Above 15% is considered healthy but always compare Globus Medical to the Medical Devices industry mean.
An Operating Margin of 3.5% means the company generated $0.04 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Globus Medical:

The MRQ is 3.5%. The company is operating less efficient.
The TTM is 18.9%. The company is operating efficient. +1

Trends

Current period		Compared to		+/-
MRQ	3.5%	TTM	18.9%	-15.4%
TTM	18.9%	YOY	22.3%	-3.3%
TTM	18.9%	5Y	19.9%	-1.0%
5Y	19.9%	10Y	23.9%	-4.0%

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	3.5%	-24.1%	+27.6%
TTM	18.9%	-16.9%	+35.8%
YOY	22.3%	-13.4%	+35.7%
5Y	19.9%	-19.2%	+39.1%
10Y	23.9%	-24.0%	+47.9%

Measures how efficient Globus Medical is operating .

The more effecient a company creates products or provides services, the more profit it generates.

How to use operating margin

Higher is better
Above 15% is considered healthy but always compare Globus Medical to the Medical Devices industry mean.
Can be very different between industries
Can be used to compare companies

Why do investors use operating margin in their analysis

To determine how much profit Globus Medical is making from it’s core business.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Operating Margin of Globus Medical is 3.5%. This means that Globus Medical earned $0.04 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Margin of the Medical Devices industry is -24.1%.
What is the trend?
The trend is important because it shows you how Globus Medical is performing over time. The most recent quarter might be important if Globus Medical released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Globus Medical up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Can be calculated in different ways

How to calculate operating margin

Operating margin = operating earnings / total revenue

Real example of Globus Medical

You need the following data to determine operating margin:

Income statement
Operating earnings MRQ Globus Medical = 10,123
Total revenue MRQ Globus Medical = 616,534
$10,123 / $616,534 = 0.04 or 3.5%

Operating margin is used to calculate how much profit a company makes after variable costs of production but before paying interest and taxes. Some variable costs examples are wages, raw materials, packaging, and transaction fees. The amount of variable costs is different for each company and industry. In general, a higher operating margin is better as this implicates that a company is running efficiently.

For investors, a higher operating margin is a good sign. Although you should always look at operating margin in the long term. If operating margin is fluctuating over the years this might be a sign that things are not running efficiently enough. It’s a way to check how much profit a company is making from its core business.

Operation earnings can be calculated in multiple ways:

Operation earnings = EBIT - non operating income + non operating expense
Operation earnings = Gross profit - operating expense - depreciation and amortisation
Operation earnings = Total revenue - COGS (costs of goods sold) - indirect costs

1.2.2. Operating Ratio

Measures how efficient Globus Medical is keeping operating costs low.

Below 1 is considered healthy (always compare to Medical Devices industry mean).
An Operation Ratio of 0.96 means that the operating costs are $0.96 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Globus Medical:

The MRQ is 0.958. The company is less efficient in keeping operating costs low.
The TTM is 0.846. The company is less efficient in keeping operating costs low.

Trends

Current period		Compared to		+/-
MRQ	0.958	TTM	0.846	+0.112
TTM	0.846	YOY	0.770	+0.077
TTM	0.846	5Y	0.813	+0.033
5Y	0.813	10Y	0.768	+0.046

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	0.958	1.431	-0.473
TTM	0.846	1.426	-0.580
YOY	0.770	1.503	-0.733
5Y	0.813	1.440	-0.627
10Y	0.768	1.371	-0.603

Measures how efficient Globus Medical is keeping operating costs low.

If the operating ratio is below 1 that means the company is making money. The lower the operating ratio, the more efficient the company.

How to use operating ratio

Lower is better.
Below 1 is considered healthy but always compare Globus Medical to the Medical Devices industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use operating ratio in their analysis

Shows if costs of creating products and or services is increasing or decreasing. The lower the operating ratio, the more efficient the company is creating products and services.

The three steps every investor should look at:

What is the current Operatin ratio?
The current most recent quarter (MRQ) Operating Ratio of Globus Medical is 95.8%. This means that Globus Medical earned $0.96 for each $1 in net sales in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Ratio of the Medical Devices industry is 1.43.
What is the trend?
The trend is important because it shows you how Globus Medical is performing over time. The most recent quarter might be important if Globus Medical released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Globus Medical up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
You need COGS to calculate operating ratio which is not always shown in the income statement.
Does not consider debt.

How to calculate operating ratio

Operating ratio = Operating expenses + COGS \ Net sales

Real life example Globus Medical

You need the following data to determine operating ratio:

Income statement

COGS is not always specified on the income statement. If so you can use the following calculation:

(cost of revenue + total operating expenses) \ total revenue
(265,486 +325,094) \ 616,534 = 0.96

The operating ratio measures the efficiency of a company at keeping low costs while generating profits from sales. It compares the total operating expenses to the net amount of sales. The total operating expenses exists of:

COGS (materials, labour, rent of facility, repairs)
Operating expenses (legal fees, marketing, wages, rent, maintenance/repairs)

Operating expenses are all the costs the company makes that are not directly tied to the production of the service or product. Where COGS are costs that are directly tied to the production of a product or service.

Do note that COGS is not always available in the income statement. Some companies include COGS in the operating expenses while others list COGS separately. To make it even more confusing, COGS is also known as “costs of sales” and costs of sales is the same as costs of revenue.

The operating ratio tells you how efficient the company is creating its products or services while keeping prices low. In this case, a lower ratio is better. Higher or rising operating ratios might tell you that costs are rising while sales are not improving or staying the same.

1.3. Liquidity of Globus Medical.

1.3. Liquidity

1.3.1. Current Ratio

Measures if Globus Medical is able to pay off Short-term Debt.

Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
A Current Ratio of 4.88 means the company has $4.88 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Globus Medical:

The MRQ is 4.882. The company is very able to pay all its short-term debts. +2
The TTM is 5.885. The company is very able to pay all its short-term debts. +2

Trends

Current period		Compared to		+/-
MRQ	4.882	TTM	5.885	-1.003
TTM	5.885	YOY	6.273	-0.388
TTM	5.885	5Y	6.594	-0.709
5Y	6.594	10Y	6.660	-0.066

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	4.882	2.754	+2.128
TTM	5.885	2.763	+3.122
YOY	6.273	3.488	+2.785
5Y	6.594	3.617	+2.977
10Y	6.660	3.514	+3.146

Measures if Globus Medical is able to pay off Short-term Debt.

How to use current ratio

Higher is better
Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
Can be very different between industries
Can be used to compare companies

Why do investors use current ratio in their analysis

Shows if the company can pay of short term debts if needed. A company that can't pay off it's short term debts might get in trouble if they have to pay off their short term debts for whatever reason. For example, markets can change due to global events like covid-19 or the war in Ukraine versus Russia. Because debts are always taken based on future income, it might become troublesome for Globus Medical if something happens in the market that will cause sales to plummet.

The three steps every investor should look at:

What is the current current Ratio?
The current most recent quarter (MRQ) Current Ratio of Globus Medical is 4.88. This means Globus Medical has $4.88 in assets for each $1 in short-term debts.
How does it compare to the industry?
The mean MRQ Current Ratio of the Medical Devices industry is 2.75.
What is the trend?
The trend is important because it shows you how Globus Medical is performing over time. The most recent quarter might be important if Globus Medical released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Globus Medical up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Might be deluded.
Not all assets can always be quickly sold.
Can be manipulated by increasing or decreasing the assets and/or liabilities.

How to calculate current ratio

Current ratio = current assets \ current liabilities

Real life example Globus Medical

You need the following data to determine operating ratio:

Balance sheet
Current ratio = current assets \ current liabilities
1,915,374 \ 392,347) = 4.88

The current ratio measures if Globus Medical is able to pay short-term debts (obligations). Short term in this context means all debt obligations that are about to expire within one year. The current ratio incorporates current liabilities and current assets. Current assets are all the assets a company has that are expected to be consumed or sold within standard business operations. You can find the current assets in the balance sheet. They consist of:

Inventory
Accounts receivable
Marketable securities
Prepaid expenses
Cash
Cash equivalents
liquid assets

The current liabilities are short term obligations that are due within one year. These consist of:

Short term debts
Dividends
Income taxes
Short-term debts
Accounts payable
Interest payments

The result shows an investor if Globus Medical is able to pay all its short-term debts if they were due all at once. When the result of the above formula is below 1, then Globus Medical does not have enough capital after selling all its assets to pay all short-term debts. If the ratio drops far below 1 that might indicate Globus Medical is or will be in financial trouble anytime soon.

Although this gives an investor some clues, the current ratio may also be deluded. Because owning assets does not mean the company can easily sell them. Also, Accounts receivable may be quite old (they will probably never pay) which deludes the current ratio. As with all ratios, you should only compare them between the same industries and companies.

1.3.2. Quick Ratio

Measures if Globus Medical is able to pay off Short-term Debt but only using the most liquid assets.

Above 1 is considered healthy but always compare Globus Medical to the Medical Devices industry mean.
A Quick Ratio of 2.74 means the company can pay off $2.74 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Globus Medical:

The MRQ is 2.735. The company is very able to pay all its short-term debts with the most liquid assets. +2
The TTM is 4.744. The company is very able to pay all its short-term debts with the most liquid assets. +2

Trends

Current period		Compared to		+/-
MRQ	2.735	TTM	4.744	-2.009
TTM	4.744	YOY	6.074	-1.330
TTM	4.744	5Y	5.985	-1.241
5Y	5.985	10Y	6.682	-0.697

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	2.735	1.532	+1.203
TTM	4.744	1.656	+3.088
YOY	6.074	2.139	+3.935
5Y	5.985	2.301	+3.684
10Y	6.682	2.255	+4.427

Measures if Globus Medical is able to pay off Short-term Debt but only using the most liquid assets.

How to use quick ratio

Higher is better.
Above 1 is considered healthy but always compare Globus Medical to the Medical Devices industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use quick ratio in their analysis

Shows how fast Globus Medical can pay off its short term debts. This shows if Globus Medical can survive emergencies due to market changes or other reasons.

The three steps every investor should look at:

What is the current Quick Ratio?
The current most recent quarter (MRQ) quickRatio of Globus Medical is 2.74. This means that Globus Medical can pay off $2.74 for each $1 in debt (using most liquid assets).
How does it compare to the industry?
The mean MRQ Quick Ratio of the Medical Devices industry is 1.53.
What is the trend?
The trend is important because it shows you how Globus Medical is performing over time. The most recent quarter might be important if Globus Medical released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Globus Medical up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Incorporates only most liquid assets.

How to calculate quick ratio

Quick ratio = cash and equivalents + marketable securities + accounts receivable / current liabilities

Real life example Globus Medical

You need the following data to determine operating ratio:

Balance sheet
Quick ratio = cash and short-term investments + short-term investments + netReceivables / total current liabilities
MRQ quick ratio Globus Medical: (517,789 + 50,497 +504,870) / 392,347 = 2.74

The quick ratio measures the same thing as the current ratio, only it uses the most liquid assets a company has. Meaning, the assets that can be sold for cash the easiest and fastest.

As the quick ratio only incorporates the most liquid assets, you should also check the current ratio which also includes less liquid assets. But they may be harder to sell.

1.4. Solvency of Globus Medical.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Measures how much % of Globus Medical assets are financed with debt.

Below 1 (100%) is considered healthy but always compare Globus Medical to Medical Devices industry mean.
A Debt to Asset Ratio of 0.21 means that Globus Medical assets are financed with 21.4% credit (debt) and the remaining percentage (100% - 21.4%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Globus Medical:

The MRQ is 0.214. The company is very able to pay all its debts by selling its assets. +2
The TTM is 0.161. The company is very able to pay all its debts by selling its assets. +2

Trends

Current period		Compared to		+/-
MRQ	0.214	TTM	0.161	+0.053
TTM	0.161	YOY	0.109	+0.052
TTM	0.161	5Y	0.108	+0.053
5Y	0.108	10Y	0.114	-0.006

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	0.214	0.389	-0.175
TTM	0.161	0.386	-0.225
YOY	0.109	0.338	-0.229
5Y	0.108	0.442	-0.334
10Y	0.114	0.460	-0.346

Measures how much % of Globus Medical assets are financed with debt.

When there are more debts than assets, that means creditors have a larger stake Globus Medical than its shareholders.

How to use debt to asset ratio

Lower is better.
below 1 (100%) is considered healthy but always compare Globus Medical to Medical Devices industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to asset ratio in their analysis

It shows how much debt the company used to finance its assets. If a company is almost entirely financed with debt that means the company might get into serious trouble when emergencies arise like a raise in interest.

The three steps every investor should look at:

What is the current debt to asset ratio?
The current most recent quarter (MRQ) Debt to Asset Ratio of Globus Medical is 0.21. This means means that Globus Medical is financed with 21.4% credit and the remaining percentage is financed by it's owners (shareholders).
How does it compare to the industry?
The mean MRQ Current Ratio of the Medical Devices industry is 275.4%.
What is the trend?
The trend is important because it shows you how Globus Medical is performing over time. The most recent quarter might be important if Globus Medical released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Globus Medical up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Some companies can have higher debt to assets ratio's (for example, banks).
Debt to asset ratio should improve over the years.
If the debt to asset ratio is above 1, look at the industry mean and find out why Globus Medical has so much debt.

How to calculate debt to asset ratio

Debt to asset ratio = total debt \ total assets

Real life example Globus Medical

You need the following data to determine debt to asset ratio:

Balance sheet
Debt to asset ratio = total debt \ total assets
1,088,124 \ 5,086,083 = 21.4% or 0.21.

The debt to total assets ratio shows if the company is owned by creditors or shareholders. Or in other words, the total debt in relation to the total amount of assets. It shows how much debt the company used to finance its assets.

1.4.2. Debt to Equity Ratio

Measures if Globus Medical is able to pay off its debts by using shareholders equity.

Below 2 is considered healthy but always compare Globus Medical to the Medical Devices industry mean.
A Debt to Equity ratio of 27.2% means that company has $0.27 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Globus Medical:

The MRQ is 0.272. The company is very able to pay all its debts with equity. +2
The TTM is 0.197. The company is very able to pay all its debts with equity. +2

Trends

Current period		Compared to		+/-
MRQ	0.272	TTM	0.197	+0.075
TTM	0.197	YOY	0.123	+0.074
TTM	0.197	5Y	0.123	+0.074
5Y	0.123	10Y	0.130	-0.007

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	0.272	0.559	-0.287
TTM	0.197	0.560	-0.363
YOY	0.123	0.478	-0.355
5Y	0.123	0.624	-0.501
10Y	0.130	0.674	-0.544

Measures if Globus Medical is able to pay off its debts by using shareholders equity.

How to use debt to equity ratio

Lower is better.
Below 2 is considered healthy (always use industry average).
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to shareholders equity ratio in their analysis

It shows how much debt the company uses to finance their operations. Shareholders equity is whats left over when you subtract total liabilities from total assets. It's another way to meassure how much of Globus Medical is financed with debt or own resources.

The three steps every investor should look at:

What is the current debt to equity ratio?
The current most recent quarter (MRQ) quickRatio of Globus Medical is 0.27. This means that Globus Medical can pay off $0.27 for each $1 in debt.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Medical Devices industry is 0.56.
What is the trend?
The trend is important because it shows you how Globus Medical is performing over time. The most recent quarter might be important if Globus Medical released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Globus Medical up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Not all debt is equally risky (for example, short term risk is less risky).

How to calculate debt to equity ratio

Debt to equity ratio = total debt \ shareholders equity.

Real life example Globus Medical

You need the following data to determine equity ratio:

Balance sheet
Debt to equity ratio = total debt \ shareholders equity
1,088,124 \ 3,997,959 = 0.27 or 27.2%

Debt to equity measures the total debt versus the total shareholders equity. While the total debts to total assets ratio uses total assets, the debt to equity ratio looks at the total equity of shareholders. Where equity of shareholders are:

Common shares.
Preferred shares.
Retained earnings.

You can find the shareholders' equity in the balance sheet. A ratio between 0,5 and 1,5 is preferred. If the ratio is above 1.5, that would indicate creditors have significantly more stake (debt) in the company than the shareholders. In other words, the company is using a lot of debt to finance their operations.

Not all debt is equally risky. Meaning you can adjust the ratio by including or excluding certain amounts of debt. Short term debts are less risky because they have to be paid back within one year anyway. It’s much easier to plan one year ahead versus five or ten years.

2. Market Valuation of Globus Medical

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Globus Medical generates.

Above 15 is considered overpriced but always compare Globus Medical to the Medical Devices industry mean.
A PE ratio of 123.19 means the investor is paying $123.19 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Globus Medical:

The EOD is 116.398. Based on the earnings, the company is expensive. -2
The MRQ is 123.195. Based on the earnings, the company is expensive. -2
The TTM is 404.555. Based on the earnings, the company is expensive. -2

Trends

Current period		Compared to		+/-
EOD	116.398	MRQ	123.195	-6.797
MRQ	123.195	TTM	404.555	-281.361
TTM	404.555	YOY	40.272	+364.284
TTM	404.555	5Y	112.336	+292.220
5Y	112.336	10Y	71.416	+40.920

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
EOD	116.398	-0.997	+117.395
MRQ	123.195	-1.578	+124.773
TTM	404.555	-2.041	+406.596
YOY	40.272	-2.761	+43.033
5Y	112.336	-2.064	+114.400
10Y	71.416	-1.463	+72.879

Measures how much money you pay for each share for every $1 in earnings Globus Medical generates.

Indicates if the company’s shares are under or overvalued.

How to use PE ratio

Above 15 is considered overpriced but is hard to determine. Always compare Globus Medical to the Medical Devices industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use PE ratio in their analysis

The PE ratio tells investors the current sentiment in the market for that company. As with every stock, the stock price never shows the real valuation of a company but rather how the market thinks how much the stock is worth.

In other words, the current stock price also incorporates any future earnings or business opportunities in the future. The best example is the stock market crash in 2000. The PE ratio for any internet based company was going through the roof. Only based on the general assumption the internet and all associated businesses would thrive in the future. But this was based on nothing. A business still needs a good product or service to be able to survive. Instead, every investor bought any stock which did something related to the internet. Result: huge market crash.

Many investors were willing to pay premium prices and that was causing the PE ratio to rise. A high PE ratio is a warning sign that investors might be overvaluing a stock based on future earnings.

The three steps every investor should look at:

What is the current PE Ratio?
The current most recent quarter (MRQ) PE Ratio of Globus Medical is 123.19. This means the investor is paying $123.19 for every $1 in earnings.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Medical Devices industry is -1.58.
What is the trend?
The trend is important because it shows you how Globus Medical is performing over time. The most recent quarter might be important if Globus Medical released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Globus Medical up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Some industries might have very high or very low PE ratios in general.
PE ratios can be high for several years, it does not mean a sudden collapse is imminent.
Earnings growth is not included in the PE ratio.

How to calculate PE ratio

PE ratio = market value per share \ earnings per share

Real life example Globus Medical

You need the following data to determine the PE ratio:

Balance sheet
Income statement

The PE ratio is a very commonly used ratio to determine the value of a company by comparing the current stock price relative to its earnings per share (EPS). Before we can calculate the PE ratio we need to know the EPS. EPS is calculated as follows:

EPS = (net profit - preferred dividends) \ end of period outstanding shares*
Net profit = revenue - expenses
0 \ 139,021 = EPS
PE ratio MRQ = 123.19

* The net profit minus preferred dividends can be found in the incomestatement as netIncomeApplicableToCommonShares.

The PE value helps investors to determine if the current stock price is under or overvalued. It also projects future growth.

In general, a higher PE ratio means that investors predict higher future growth. If the PE ratio is too high, then investors expect way too much future growth the company can never fulfil. This is most likely to happen in faster moving companies like tech companies or automobile companies like Tesla. These are hot and booming markets where investors expect much future growth driven by new technology (electric cars). When looking at the current MRQ (most recent quarter) PE ratio of Tesla ( jan. 2021) it's about 247 while the average in the industry is only 6. That might be a clue that Tesla is trading for way too high prices compared to their current assets and is more based on future growth.

2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Globus Medical:

The EOD is 21.395. Based on how much money comes from the company's main activities, the company is underpriced. +1
The MRQ is 22.644. Based on how much money comes from the company's main activities, the company is underpriced. +1
The TTM is 53.219. Based on how much money comes from the company's main activities, the company is overpriced. -1

Trends

Current period		Compared to		+/-
EOD	21.395	MRQ	22.644	-1.249
MRQ	22.644	TTM	53.219	-30.575
TTM	53.219	YOY	82.823	-29.604
TTM	53.219	5Y	63.849	-10.631
5Y	63.849	10Y	43.704	+20.146

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
EOD	21.395	-0.935	+22.330
MRQ	22.644	-1.489	+24.133
TTM	53.219	-2.994	+56.213
YOY	82.823	-6.238	+89.061
5Y	63.849	-4.771	+68.620
10Y	43.704	-4.736	+48.440

2. Book Value per Share

2.3. Price to Book Ratio

Measures if the stock price of Globus Medical is to cheap or to expensive compared to its book value.

At or below 1 is considered healthy (always compare to Medical Devices industry mean).
A PB ratio of 1.85 means the investor is paying $1.85 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Globus Medical:

The EOD is 1.751. Based on the equity, the company is underpriced. +1
The MRQ is 1.853. Based on the equity, the company is underpriced. +1
The TTM is 2.487. Based on the equity, the company is underpriced. +1

Trends

Current period		Compared to		+/-
EOD	1.751	MRQ	1.853	-0.102
MRQ	1.853	TTM	2.487	-0.634
TTM	2.487	YOY	4.189	-1.702
TTM	2.487	5Y	3.994	-1.507
5Y	3.994	10Y	4.173	-0.179

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
EOD	1.751	1.890	-0.139
MRQ	1.853	2.379	-0.526
TTM	2.487	2.458	+0.029
YOY	4.189	3.214	+0.975
5Y	3.994	3.833	+0.161
10Y	4.173	4.173	0.000

2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Globus Medical.

3.1. Institutions holding Globus Medical

Institutions are holding 96.975% of the shares of Globus Medical.

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2023-12-31	Vanguard Group Inc	8.3309	0.0131	11277722	32220	0.2865
2023-12-31	BlackRock Inc	8.0091	0.0147	10842057	-196362	-1.7789
2023-12-31	HHG PLC	5.8423	0.2514	7908828	-365782	-4.4205
2023-12-31	State Street Corporation	2.6143	0.0092	3539020	-71954	-1.9926
2023-12-31	Wellington Management Company LLP	2.1514	0.0289	2912454	252510	9.4931
2023-12-31	Bank of New York Mellon Corp	2.1465	0.0314	2905790	499108	20.7384
2023-12-31	William Blair Investment Management, LLC	1.694	0.3556	2293227	-23145	-0.9992
2023-12-31	Camber Capital Management LLC	1.6621	3.0557	2250000	525000	30.4348
2023-09-30	Hawk Ridge Management LLC	1.6442	5.437	2225772	537972	31.8742
2023-12-31	Millennium Management LLC	1.49	0.0465	2017037	1652528	453.3573
2023-12-31	JPMorgan Chase & Co	1.4882	0.0103	2014631	-117237	-5.4993
2023-12-31	Champlain Investment Partners, LLC	1.4779	0.6321	2000638	83262	4.3425
2023-12-31	Geode Capital Management, LLC	1.437	0.0109	1945319	69712	3.7168
2023-12-31	Dimensional Fund Advisors, Inc.	1.343	0.0283	1818087	-271786	-13.0049
2023-12-31	NORGES BANK	1.3243	0.0167	1792784	1042120	138.8264
2023-12-31	GW&K Investment Management, LLC	1.3001	0.8745	1759983	96713	5.8146
2023-12-31	Burgundy Asset Management Ltd	1.254	1.0035	1697552	663782	64.2098
2023-12-31	Marshall Wace Asset Management Ltd	1.2075	0.1475	1634570	248492	17.9277
2023-12-31	Van Berkom and Associates Inc	1.1649	2.4444	1576940	127553	8.8005
2023-12-31	Geneva Capital Management	1.0504	1.4309	1421899	-325	-0.0229
Total		48.6321	15.8426	65834310	+4784381	+7.3%

3.2. Funds holding Globus Medical

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2024-02-29	Vanguard Total Stock Mkt Idx Inv	2.7221	0.0128	3684988	-8573	-0.2321
2024-02-29	iShares Core S&P Mid-Cap ETF	2.5942	0.2353	3511895	-10137	-0.2878
2024-02-29	Vanguard Small Cap Index	2.2501	0.117	3045967	28341	0.9392
2023-12-31	Vanguard Explorer Inv	1.4633	0.4937	1980941	156666	8.5878
2023-12-31	Janus Henderson US Opportunistic Alpha	1.3917	2.1866	1884016	-438948	-18.896
2023-12-31	Janus Henderson Contrarian D	1.3917	2.2019	1884016	-438948	-18.896
2024-02-29	Champlain Small Company Fund, LLC	1.3135	2.0727	1778078	264320	17.4612
2024-02-29	Vanguard Small Cap Growth Index Inv	1.2632	0.2645	1709999	26943	1.6008
2024-02-29	Vanguard Institutional Extnd Mkt Idx Tr	1.2617	0.0904	1707934	4823	0.2832
2023-12-31	Janus Henderson US SMID Cap Growth	1.2296	1.3063	1664580	43910	2.7094
2023-12-31	Janus Henderson Triton D	1.2296	1.3008	1664580	43910	2.7094
2023-10-31	Nuance Mid Cap Value Institutional	1.218	3.0209	1648819	174026	11.8
2023-12-31	JPM US Mid Cap Value-Composite	0.9588	0.5258	1297949	-24982	-1.8884
2024-01-31	JPMorgan Mid Cap Value L	0.9588	0.5271	1297949	0	0
2024-02-29	SPDR® S&P MIDCAP 400 ETF Trust	0.6806	0.2366	921410	3468	0.3778
2023-12-31	Janus Henderson Global Life Sciences	0.6493	0.9563	879014	44522	5.3352
2023-12-31	Janus Henderson Global Life Sciences D	0.6493	0.9518	879014	44522	5.3352
2023-12-31	Champlain Small Company Adv	0.6057	1.7843	820000	25000	3.1447
2024-02-29	iShares US Medical Devices ETF	0.5748	0.7642	778056	0	0
2024-01-31	BNY Mellon Dynamic Value Fund A	0.5706	0.9168	772498	160615	26.2493
Total		24.9766	19.9658	33811703	+99478	+0.3%

3.3. Insider Transactions

Insiders are holding 0.792% of the shares of Globus Medical.

Date	Owner	Type	Amount	Price	Post Transaction Amount	Link
2024-03-15	Leslie V Norwalk	SELL	10590	51.99
2023-05-15	Dan Lemaitre	SELL	43450	56.98

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Globus Medical compared to the Most Recent Quarter (MRQ).

	End of day	+/-	Most Recent Quarter	Trailing 12 Months	+/-	Year-Over-Year	+/-	5 Year	+/-	10 Year	+/-
Book Value Change Per Share	-	-	-7.576	3.102	-344%	0.232	-3360%	0.913	-930%	0.614	-1333%
Book Value Per Share	-	-	28.758	24.905	+15%	15.705	+83%	15.892	+81%	11.513	+150%
Current Ratio	-	-	4.882	5.885	-17%	6.273	-22%	6.594	-26%	6.660	-27%
Debt To Asset Ratio	-	-	0.214	0.161	+33%	0.109	+96%	0.108	+98%	0.114	+88%
Debt To Equity Ratio	-	-	0.272	0.197	+38%	0.123	+122%	0.123	+121%	0.130	+109%
Dividend Per Share	-	-	-	-	0%	-	0%	-	0%	-	0%
Eps	-	-	0.108	0.266	-59%	0.421	-74%	0.317	-66%	0.286	-62%
Free Cash Flow Per Share	-	-	0.588	0.330	+78%	0.231	+155%	0.314	+87%	0.265	+122%
Free Cash Flow To Equity Per Share	-	-	-1.118	-0.084	-92%	-0.012	-99%	0.200	-659%	0.220	-608%
Gross Profit Margin	-	-	1.000	1.000	0%	1.000	0%	1.000	+0%	1.000	+0%
Intrinsic Value_10Y_max	-	-	17.856	-	-	-	-	-	-	-	-
Intrinsic Value_10Y_min	-	-	8.104	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_max	-	-	1.455	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_min	-	-	1.024	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_max	-	-	4.627	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_min	-	-	2.911	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_max	-	-	8.106	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_min	-	-	4.603	-	-	-	-	-	-	-	-
Market Cap	5686629700.000	-30%	7408429090.000	6562986225.000	+13%	7447395480.000	-1%	6725173182.000	+10%	5119427636.500	+45%
Net Profit Margin	-	-	0.024	0.101	-76%	0.185	-87%	0.150	-84%	0.172	-86%
Operating Margin	-	-	0.035	0.189	-81%	0.223	-84%	0.199	-82%	0.239	-85%
Operating Ratio	-	-	0.958	0.846	+13%	0.770	+24%	0.813	+18%	0.768	+25%
Pb Ratio	1.751	-6%	1.853	2.487	-25%	4.189	-56%	3.994	-54%	4.173	-56%
Pe Ratio	116.398	-6%	123.195	404.555	-70%	40.272	+206%	112.336	+10%	71.416	+73%
Price Per Share	50.350	-6%	53.290	54.780	-3%	65.940	-19%	58.880	-9%	44.995	+18%
Price To Free Cash Flow Ratio	21.395	-6%	22.644	53.219	-57%	82.823	-73%	63.849	-65%	43.704	-48%
Price To Total Gains Ratio	-6.646	+6%	-7.034	46.201	-115%	80.353	-109%	72.591	-110%	85.959	-108%
Quick Ratio	-	-	2.735	4.744	-42%	6.074	-55%	5.985	-54%	6.682	-59%
Return On Assets	-	-	0.003	0.013	-77%	0.024	-88%	0.020	-85%	0.026	-89%
Return On Equity	-	-	0.004	0.015	-74%	0.027	-86%	0.022	-83%	0.029	-87%
Total Gains Per Share	-	-	-7.576	3.102	-344%	0.232	-3360%	0.913	-930%	0.614	-1333%
Usd Book Value	-	-	3997959000.000	3021282250.000	+32%	1773737250.000	+125%	1836588550.000	+118%	1321161625.000	+203%
Usd Book Value Change Per Share	-	-	-7.576	3.102	-344%	0.232	-3360%	0.913	-930%	0.614	-1333%
Usd Book Value Per Share	-	-	28.758	24.905	+15%	15.705	+83%	15.892	+81%	11.513	+150%
Usd Dividend Per Share	-	-	-	-	0%	-	0%	-	0%	-	0%
Usd Eps	-	-	0.108	0.266	-59%	0.421	-74%	0.317	-66%	0.286	-62%
Usd Free Cash Flow	-	-	81793000.000	41306250.000	+98%	26105250.000	+213%	36269100.000	+126%	30303975.000	+170%
Usd Free Cash Flow Per Share	-	-	0.588	0.330	+78%	0.231	+155%	0.314	+87%	0.265	+122%
Usd Free Cash Flow To Equity Per Share	-	-	-1.118	-0.084	-92%	-0.012	-99%	0.200	-659%	0.220	-608%
Usd Market Cap	5686629700.000	-30%	7408429090.000	6562986225.000	+13%	7447395480.000	-1%	6725173182.000	+10%	5119427636.500	+45%
Usd Price Per Share	50.350	-6%	53.290	54.780	-3%	65.940	-19%	58.880	-9%	44.995	+18%
Usd Profit	-	-	15034000.000	30718250.000	-51%	47542500.000	-68%	35986450.000	-58%	32329025.000	-53%
Usd Revenue	-	-	616534000.000	392119000.000	+57%	255710750.000	+141%	256191550.000	+141%	201397375.000	+206%
Usd Total Gains Per Share	-	-	-7.576	3.102	-344%	0.232	-3360%	0.913	-930%	0.614	-1333%
	EOD	+5 -3	MRQ	TTM	+13 -20	YOY	+10 -23	5Y	+13 -21	10Y	+13 -21

4.2. Fundamental Score

Let's check the fundamental score of Globus Medical based on Penke's default stock scanner.

Penke's Stock Scanner

Indicator	Condition		Value
Price to Earnings Ratio (EOD)	Between	0-15	116.398
Price to Book Ratio (EOD)	Between	0-1	1.751
Net Profit Margin (MRQ)	Greater than	0	0.024
Operating Margin (MRQ)	Greater than	0	0.035
Quick Ratio (MRQ)	Greater than	1	2.735
Current Ratio (MRQ)	Greater than	1	4.882
Debt to Asset Ratio (MRQ)	Less than	1	0.214
Debt to Equity Ratio (MRQ)	Less than	1	0.272
Return on Equity (MRQ)	Greater than	0.15	0.004
Return on Assets (MRQ)	Greater than	0.05	0.003
Total			6/10 (60.0%)

Create your own Stock Scanner

Investing is personal. The best investors buy stocks based on their own analysis. Create your personal Stock Scanner with the key performance indicators that are important to you.
Create your own Stock Scanner

4.3. Technical Score

Let's check the technical score of Globus Medical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	37.748
Ma 20	Greater than	Ma 50	52.092
Ma 50	Greater than	Ma 100	53.138
Ma 100	Greater than	Ma 200	52.360
Open	Greater than	Close	51.030
Total			2/5 (40.0%)

Create your own Symbol Scanner

Trading is personal. The best traders buy and sell based on their own technical analysis. Create your personal Symbol Scanner with the technical indicators that are important to you.
Create your own Symbol Scanner

Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

		2022-12-31		2023-03-31		2023-06-30		2023-09-30		2023-12-31
Net Interest Income		5,315	1,182	6,497	1,797	8,294	-374	7,920	-10,501	-2,581

Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary

Total Assets	5,086,083
Total Liabilities	1,088,124
Total Stockholder Equity	3,997,959

	As reported
Total Liabilities	1,088,124
Total Stockholder Equity	+ 3,997,959
Total Assets	= 5,086,083

Assets

Total Assets	5,086,083
Total Current Assets	1,915,374
Long-term Assets	3,170,709

Total Current Assets

Total Current Assets (as reported)	1,915,374
Cash And Cash Equivalents	467,292
Short-term Investments	50,497
Net Receivables	504,870
Inventory	848,135
Other Current Assets	44,580
Total Current Assets (calculated)	1,915,374
+/-	0

Long-term Assets

Long-term Assets (as reported)	3,170,709
Property Plant Equipment	646,863
Goodwill	1,434,540
Long Term Investments	75,428
Intangible Assets	924,603
Long-term Assets Other	78,590
Long-term Assets (calculated)	3,160,024
+/-	10,685

Liabilities & Shareholders' Equity

Total Current Liabilities	392,347
Long-term Liabilities	695,777
Total Stockholder Equity	3,997,959

Total Current Liabilities

Total Current Liabilities (as reported)	392,347
Short-term Debt	11,967
Accounts payable	56,671
Other Current Liabilities	305,340
Total Current Liabilities (calculated)	373,978
+/-	18,369

Long-term Liabilities

Long-term Liabilities (as reported)	695,777
Long term Debt	417,400
Capital Lease Obligations	103,004
Long-term Liabilities Other	102,919
Long-term Liabilities (calculated)	623,323
+/-	72,454

Total Stockholder Equity

Total Stockholder Equity (as reported)	3,997,959
Common Stock	136
Retained Earnings	1,137,266
Accumulated Other Comprehensive Income	-10,192
Other Stockholders Equity	2,870,749
Total Stockholder Equity (calculated)	3,997,959
+/-	0

Other

Capital Stock	136
Cash and Short Term Investments	517,789
Common Stock Shares Outstanding	139,021
Current Deferred Revenue	18,369
Liabilities and Stockholders Equity	5,086,083
Net Debt	53,112
Net Invested Capital	4,415,359
Net Working Capital	1,523,027
Property Plant and Equipment Gross	1,072,558
Short Long Term Debt Total	520,404

Balance Sheet

Currency in USD. All numbers in thousands.

Trend

2023-12-31

2023-09-30

2023-06-30

2023-03-31

2022-12-31

2022-09-30

2022-06-30

2022-03-31

2021-12-31

2021-09-30

2021-06-30

2021-03-31

2020-12-31

2020-09-30

2020-06-30

2020-03-31

2019-12-31

2019-09-30

2019-06-30

2019-03-31

2018-12-31

2018-09-30

2018-06-30

2018-03-31

2017-12-31

2017-09-30

2017-06-30

2017-03-31

2016-12-31

2016-09-30

2016-06-30

2016-03-31

2015-12-31

2015-09-30

2015-06-30

2015-03-31

2014-12-31

2014-09-30

2014-06-30

2014-03-31

2013-12-31

2013-09-30

2013-06-30

2013-03-31

2012-12-31

2012-09-30

2012-06-30

2012-03-31

2011-12-31

2011-09-30

2011-06-30

2011-03-31

2010-12-31

> Total Assets

266,575
0
0
0
329,390
354,809
367,304
416,042
447,133
473,620
498,075
524,672
566,304
599,422
618,000
646,439
703,547
744,129
764,663
800,661
834,100
839,988
869,476
901,743
927,637
960,421
995,014
1,037,160
1,078,502
1,127,660
1,193,833
1,238,506
1,300,670
1,335,919
1,390,746
1,452,182
1,532,077
1,479,365
1,465,802
1,541,739
1,679,485
1,737,890
1,830,213
1,910,578
1,957,263
1,998,694
1,914,712
1,976,512
2,076,126
2,149,620
2,212,465
5,355,875
5,086,083

5,086,083

5,355,875

2,212,465

2,149,620

2,076,126

1,976,512

1,914,712

1,998,694

1,957,263

1,910,578

1,830,213

1,737,890

1,679,485

1,541,739

1,465,802

1,479,365

1,532,077

1,452,182

1,390,746

1,335,919

1,300,670

1,238,506

1,193,833

1,127,660

1,078,502

1,037,160

995,014

960,421

927,637

901,743

869,476

839,988

834,100

800,661

764,663

744,129

703,547

646,439

618,000

599,422

566,304

524,672

498,075

473,620

447,133

416,042

367,304

354,809

329,390

266,575

> Total Current Assets

0
0
0
0
258,775
282,744
293,768
333,432
360,110
323,435
337,882
384,764
416,808
460,901
467,100
484,813
470,025
455,695
454,756
506,308
544,799
515,498
535,429
478,210
513,766
540,899
535,129
563,562
620,342
614,925
633,224
646,401
630,681
617,568
583,933
637,063
687,468
641,800
696,891
811,951
821,765
814,373
891,998
980,514
864,516
916,598
891,168
920,001
983,344
1,070,429
1,210,010
1,917,337
1,915,374

1,915,374

1,917,337

1,210,010

1,070,429

983,344

920,001

891,168

916,598

864,516

980,514

891,998

814,373

821,765

811,951

696,891

641,800

687,468

637,063

583,933

617,568

630,681

646,401

633,224

614,925

620,342

563,562

535,129

540,899

513,766

478,210

535,429

515,498

544,799

506,308

454,756

455,695

470,025

484,813

467,100

460,901

416,808

384,764

337,882

323,435

360,110

333,432

293,768

282,744

258,775

Cash And Cash Equivalents

111,701
0
0
0
142,668
159,098
165,577
195,156
212,400
131,543
92,314
101,907
89,962
104,602
136,500
169,449
82,265
75,006
41,559
50,501
60,152
81,275
95,342
90,192
132,639
182,435
149,669
154,855
118,817
119,836
119,944
145,295
139,747
129,976
117,790
166,090
195,724
166,742
165,554
250,607
239,397
184,848
268,783
361,876
193,069
229,789
150,772
134,223
150,466
217,685
306,452
279,620
467,292

467,292

279,620

306,452

217,685

150,466

134,223

150,772

229,789

193,069

361,876

268,783

184,848

239,397

250,607

165,554

166,742

195,724

166,090

117,790

129,976

139,747

145,295

119,944

119,836

118,817

154,855

149,669

182,435

132,639

90,192

95,342

81,275

60,152

50,501

41,559

75,006

82,265

169,449

136,500

104,602

89,962

101,907

92,314

131,543

212,400

195,156

165,577

159,098

142,668

111,701

Short-term Investments

0
0
0
0
0
0
0
0
0
30,785
68,844
111,239
148,962
176,204
139,765
129,302
146,439
138,274
158,247
188,101
220,877
236,856
229,170
167,727
157,673
143,663
162,520
182,804
254,890
249,341
240,976
227,466
199,937
190,688
122,637
111,402
115,763
110,211
151,181
159,030
187,344
218,711
191,644
191,319
250,378
243,505
257,238
271,063
295,592
286,685
306,376
189,314
50,497

50,497

189,314

306,376

286,685

295,592

271,063

257,238

243,505

250,378

191,319

191,644

218,711

187,344

159,030

151,181

110,211

115,763

111,402

122,637

190,688

199,937

227,466

240,976

249,341

254,890

182,804

162,520

143,663

157,673

167,727

229,170

236,856

220,877

188,101

158,247

138,274

146,439

129,302

139,765

176,204

148,962

111,239

68,844

30,785

Net Receivables

0
0
0
0
50,063
54,220
53,287
58,209
58,601
64,971
71,581
61,934
65,137
64,366
69,744
64,699
81,202
73,703
79,966
85,591
86,353
75,808
89,845
92,603
95,783
94,279
105,475
105,011
127,060
125,170
140,603
135,317
144,356
140,609
156,954
157,576
162,424
138,683
136,074
151,365
148,100
162,675
185,163
176,744
165,651
169,831
198,536
208,504
217,308
225,825
241,942
495,852
504,870

504,870

495,852

241,942

225,825

217,308

208,504

198,536

169,831

165,651

176,744

185,163

162,675

148,100

151,365

136,074

138,683

162,424

157,576

156,954

140,609

144,356

135,317

140,603

125,170

127,060

105,011

105,475

94,279

95,783

92,603

89,845

75,808

86,353

85,591

79,966

73,703

81,202

64,699

69,744

64,366

65,137

61,934

71,581

64,971

58,601

58,209

53,287

54,220

50,063

Other Current Assets

17,806
0
0
0
2,515
20,155
21,782
23,029
3,020
4,358
5,456
6,086
5,080
4,744
5,412
6,183
5,742
5,054
6,811
7,107
7,351
5,961
5,420
11,605
14,502
7,008
5,879
9,430
11,166
12,998
16,943
13,951
15,387
12,915
13,512
14,835
17,243
17,713
19,625
19,091
17,771
16,132
15,200
16,207
18,417
19,587
18,579
23,803
20,997
19,201
19,684
47,574
44,580

44,580

47,574

19,684

19,201

20,997

23,803

18,579

19,587

18,417

16,207

15,200

16,132

17,771

19,091

19,625

17,713

17,243

14,835

13,512

12,915

15,387

13,951

16,943

12,998

11,166

9,430

5,879

7,008

14,502

11,605

5,420

5,961

7,351

7,107

6,811

5,054

5,742

6,183

5,412

4,744

5,080

6,086

5,456

4,358

3,020

23,029

21,782

20,155

2,515

17,806

> Long-term Assets

0
0
0
0
70,615
72,065
73,536
82,610
87,023
150,185
160,193
139,908
149,496
138,521
150,900
161,626
233,522
288,434
309,907
294,353
289,301
324,490
334,047
423,533
413,871
419,522
459,885
473,598
458,160
512,735
560,609
592,105
669,989
718,351
806,813
815,119
844,609
837,565
768,911
729,788
857,720
923,517
938,215
930,064
1,092,747
1,082,096
1,023,544
1,056,511
1,092,782
1,079,191
1,002,455
3,438,538
3,170,709

3,170,709

3,438,538

1,002,455

1,079,191

1,092,782

1,056,511

1,023,544

1,082,096

1,092,747

930,064

938,215

923,517

857,720

729,788

768,911

837,565

844,609

815,119

806,813

718,351

669,989

592,105

560,609

512,735

458,160

473,598

459,885

419,522

413,871

423,533

334,047

324,490

289,301

294,353

309,907

288,434

233,522

161,626

150,900

138,521

149,496

139,908

160,193

150,185

87,023

82,610

73,536

72,065

70,615

Property Plant Equipment

45,903
0
0
0
52,394
54,081
55,772
56,892
61,089
62,533
63,934
63,614
64,150
65,643
65,572
66,062
69,475
87,916
99,913
106,180
114,743
115,105
119,077
127,084
124,229
124,840
130,123
134,214
143,167
149,193
154,342
161,768
171,873
184,288
194,133
197,098
199,841
212,605
211,902
215,274
216,879
216,186
210,749
215,665
221,076
227,541
238,882
236,342
243,729
245,098
248,048
701,742
646,863

646,863

701,742

248,048

245,098

243,729

236,342

238,882

227,541

221,076

215,665

210,749

216,186

216,879

215,274

211,902

212,605

199,841

197,098

194,133

184,288

171,873

161,768

154,342

149,193

143,167

134,214

130,123

124,840

124,229

127,084

119,077

115,105

114,743

106,180

99,913

87,916

69,475

66,062

65,572

65,643

64,150

63,614

63,934

62,533

61,089

56,892

55,772

54,081

52,394

45,903

Goodwill

0
0
0
0
9,808
9,808
9,808
15,342
15,372
15,372
15,372
15,372
18,372
18,372
18,372
18,372
53,196
93,573
93,561
91,964
91,964
91,964
91,964
110,250
105,926
106,215
112,769
119,273
123,890
124,780
123,750
124,015
123,734
123,680
129,901
129,004
128,775
128,952
129,184
129,662
156,716
155,373
155,777
166,578
179,708
179,045
182,702
181,774
197,471
198,710
198,932
1,122,428
1,434,540

1,434,540

1,122,428

198,932

198,710

197,471

181,774

182,702

179,045

179,708

166,578

155,777

155,373

156,716

129,662

129,184

128,952

128,775

129,004

129,901

123,680

123,734

124,015

123,750

124,780

123,890

119,273

112,769

106,215

105,926

110,250

91,964

93,561

93,573

53,196

18,372

15,372

15,342

9,808

Long Term Investments

0
0
0
0
0
0
0
0
0
61,788
70,517
50,653
36,528
24,151
36,754
47,028
75,347
71,513
81,380
61,525
48,762
58,943
65,625
64,451
90,444
93,066
90,932
88,051
84,466
131,899
182,526
194,683
263,117
300,802
369,665
383,099
409,514
380,061
319,483
275,587
358,522
434,877
453,726
431,814
562,475
546,881
473,663
503,965
495,852
480,025
391,521
275,958
75,428

75,428

275,958

391,521

480,025

495,852

503,965

473,663

546,881

562,475

431,814

453,726

434,877

358,522

275,587

319,483

380,061

409,514

383,099

369,665

300,802

263,117

194,683

182,526

131,899

84,466

88,051

90,932

93,066

90,444

64,451

65,625

58,943

48,762

61,525

81,380

71,513

75,347

47,028

36,754

24,151

36,528

50,653

70,517

61,788

Intangible Assets

0
0
0
0
7,433
7,324
7,238
9,746
9,585
9,453
9,321
9,189
29,537
29,404
29,271
29,139
34,529
34,342
33,951
33,635
33,242
32,849
32,993
67,438
61,706
61,343
90,036
87,653
78,659
78,935
74,973
89,522
87,323
84,269
85,465
81,969
78,812
88,691
85,226
81,794
86,949
80,414
76,153
73,095
68,660
64,385
59,131
54,057
63,574
59,194
54,901
1,261,617
924,603

924,603

1,261,617

54,901

59,194

63,574

54,057

59,131

64,385

68,660

73,095

76,153

80,414

86,949

81,794

85,226

88,691

78,812

81,969

85,465

84,269

87,323

89,522

74,973

78,935

78,659

87,653

90,036

61,343

61,706

67,438

32,993

32,849

33,242

33,635

33,951

34,342

34,529

29,139

29,271

29,404

29,537

9,189

9,321

9,453

9,585

9,746

7,238

7,324

7,433

Long-term Assets Other

0
0
0
0
980
852
718
630
977
-23,872
-27,282
-31,319
909
-37,527
-38,386
-36,725
975
-40,251
-41,343
-42,869
590
306
302
26,015
30,928
30,954
31,051
37,447
36,280
34,954
33,869
32,559
10,364
12,962
15,671
15,212
21,741
20,568
21,070
22,851
32,039
28,693
33,147
33,574
36,334
34,307
34,007
35,654
43,311
44,985
47,215
69,478
78,590

78,590

69,478

47,215

44,985

43,311

35,654

34,007

34,307

36,334

33,574

33,147

28,693

32,039

22,851

21,070

20,568

21,741

15,212

15,671

12,962

10,364

32,559

33,869

34,954

36,280

37,447

31,051

30,954

30,928

26,015

302

306

590

-42,869

-41,343

-40,251

975

-36,725

-38,386

-37,527

909

-31,319

-27,282

-23,872

977

630

718

852

980

Deferred Long Term Asset Charges

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,323
24,086
28,295
30,638
33,104
34,974
36,127
20,031
20,474
17,816
15,391
13,578
12,350
11,978
8,737
0
6,688
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

6,688

8,737

11,978

12,350

13,578

15,391

17,816

20,474

20,031

36,127

34,974

33,104

30,638

28,295

24,086

25,323

> Total Liabilities

38,380
0
0
0
46,914
52,996
45,616
51,780
60,631
65,320
75,942
76,296
93,944
97,357
89,690
92,631
118,093
129,965
121,538
126,744
118,776
91,103
89,945
91,624
95,559
91,536
89,714
101,896
110,724
100,792
96,647
97,389
115,154
98,705
103,220
113,387
129,625
115,999
128,887
124,535
173,188
174,896
190,940
192,309
215,875
213,322
215,619
212,401
229,753
234,800
227,400
1,168,590
1,088,124

1,088,124

1,168,590

227,400

234,800

229,753

212,401

215,619

213,322

215,875

192,309

190,940

174,896

173,188

124,535

128,887

115,999

129,625

113,387

103,220

98,705

115,154

97,389

96,647

100,792

110,724

101,896

89,714

91,536

95,559

91,624

89,945

91,103

118,776

126,744

121,538

129,965

118,093

92,631

89,690

97,357

93,944

76,296

75,942

65,320

60,631

51,780

45,616

52,996

46,914

38,380

> Total Current Liabilities

31,727
0
0
0
29,271
36,087
29,025
34,074
39,508
45,274
56,635
58,480
67,942
72,491
65,970
72,759
89,412
93,311
91,733
94,419
82,691
72,337
70,280
65,807
79,892
75,369
69,061
74,927
93,073
82,552
80,280
81,718
96,118
79,492
84,184
94,921
111,403
97,962
106,126
99,980
120,792
123,677
130,042
122,525
140,164
141,491
146,017
145,255
159,204
167,547
155,220
428,722
392,347

392,347

428,722

155,220

167,547

159,204

145,255

146,017

141,491

140,164

122,525

130,042

123,677

120,792

99,980

106,126

97,962

111,403

94,921

84,184

79,492

96,118

81,718

80,280

82,552

93,073

74,927

69,061

75,369

79,892

65,807

70,280

72,337

82,691

94,419

91,733

93,311

89,412

72,759

65,970

72,491

67,942

58,480

56,635

45,274

39,508

34,074

29,025

36,087

29,271

31,727

Short-term Debt

0
0
0
0
0
0
0
0
1,747
0
0
0
16,166
0
0
0
22,006
0
0
0
15,845
0
0
0
17,674
0
0
0
35,837
46,153
50,957
50,086
60,795
49,673
51,038
61,052
74,660
60,950
71,233
62,782
88,685
86,567
91,585
83,451
94,414
0
0
0
2,536
0
1,758
13,385
11,967

11,967

13,385

1,758

2,536

94,414

83,451

91,585

86,567

88,685

62,782

71,233

60,950

74,660

61,052

51,038

49,673

60,795

50,086

50,957

46,153

35,837

17,674

15,845

22,006

16,166

1,747

Short Long Term Debt

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,141
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

1,141

Accounts payable

7,250
0
0
0
6,501
6,293
7,854
10,800
12,547
12,662
14,373
12,162
12,729
13,286
12,973
13,648
21,263
19,384
18,326
16,358
15,971
12,124
11,628
13,936
17,472
17,013
16,291
16,553
25,039
28,161
20,727
23,061
25,895
25,031
23,745
24,137
24,614
24,227
27,715
30,022
18,205
22,409
21,270
20,678
21,955
26,093
34,195
31,971
36,101
39,835
33,811
86,934
56,671

56,671

86,934

33,811

39,835

36,101

31,971

34,195

26,093

21,955

20,678

21,270

22,409

18,205

30,022

27,715

24,227

24,614

24,137

23,745

25,031

25,895

23,061

20,727

28,161

25,039

16,553

16,291

17,013

17,472

13,936

11,628

12,124

15,971

16,358

18,326

19,384

21,263

13,648

12,973

13,286

12,729

12,162

14,373

12,662

12,547

10,800

7,854

6,293

6,501

7,250

Other Current Liabilities

18,797
0
0
0
22,770
29,794
21,171
23,274
1,435
32,612
42,262
46,318
1,730
59,205
52,997
59,111
6,081
73,927
73,407
78,061
12,188
60,213
58,652
51,871
14,108
58,356
52,770
58,374
12,166
6,659
6,507
6,693
6,830
2,000
6,016
5,603
6,727
6,333
665
997
5,777
6,048
8,182
8,729
11,770
103,591
98,637
100,998
106,467
114,171
104,706
310,411
305,340

305,340

310,411

104,706

114,171

106,467

100,998

98,637

103,591

11,770

8,729

8,182

6,048

5,777

997

665

6,333

6,727

5,603

6,016

2,000

6,830

6,693

6,507

6,659

12,166

58,374

52,770

58,356

14,108

51,871

58,652

60,213

12,188

78,061

73,407

73,927

6,081

59,111

52,997

59,205

1,730

46,318

42,262

32,612

1,435

23,274

21,171

29,794

22,770

18,797

> Long-term Liabilities

0
0
0
0
17,643
16,909
16,591
17,706
21,123
20,046
19,307
17,816
26,002
24,866
23,720
19,872
28,681
36,654
29,805
32,325
36,085
18,766
19,665
25,817
15,667
16,167
20,653
26,969
17,651
18,240
16,367
15,671
19,036
19,213
19,036
18,466
18,222
18,037
22,761
24,555
52,396
51,219
60,898
69,784
75,711
71,831
69,602
67,146
70,549
67,253
72,180
739,868
695,777

695,777

739,868

72,180

67,253

70,549

67,146

69,602

71,831

75,711

69,784

60,898

51,219

52,396

24,555

22,761

18,037

18,222

18,466

19,036

19,213

19,036

15,671

16,367

18,240

17,651

26,969

20,653

16,167

15,667

25,817

19,665

18,766

36,085

32,325

29,805

36,654

28,681

19,872

23,720

24,866

26,002

17,816

19,307

20,046

21,123

17,706

16,591

16,909

17,643

Capital Lease Obligations Min Short Term Debt

0
0
0
0
0
0
0
0
-1,747
0
0
0
-16,166
0
0
0
-22,006
0
0
0
-15,845
0
0
0
-17,674
0
0
0
-35,837
-46,153
-50,957
-50,086
-60,795
-49,673
-51,038
-61,052
-74,660
-60,950
-71,233
-62,782
-88,685
-86,567
-91,585
-83,451
-94,414
0
0
0
3,475
0
-1,758
99,927
91,037

91,037

99,927

-1,758

3,475

-94,414

-83,451

-91,585

-86,567

-88,685

-62,782

-71,233

-60,950

-74,660

-61,052

-51,038

-49,673

-60,795

-50,086

-50,957

-46,153

-35,837

-17,674

-15,845

-22,006

-16,166

-1,747

Deferred Long Term Asset Charges

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,323
24,086
28,295
30,638
33,104
34,974
36,127
20,031
20,474
17,816
15,391
13,578
12,350
11,978
8,737
0
6,688
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

6,688

8,737

11,978

12,350

13,578

15,391

17,816

20,474

20,031

36,127

34,974

33,104

30,638

28,295

24,086

25,323

Long-term Liabilities Other

0
0
0
0
0
0
11,091
13,311
13,409
13,080
12,843
12,625
19,617
19,736
19,573
18,138
23,515
29,134
24,018
24,132
22,825
18,766
19,665
16,804
7,791
7,906
12,478
12,564
6,982
6,736
6,376
6,048
10,922
11,275
10,939
11,443
12,199
12,177
17,715
20,427
46,194
45,294
55,424
64,992
71,397
68,020
67,091
65,568
68,770
65,884
66,881
98,027
102,919

102,919

98,027

66,881

65,884

68,770

65,568

67,091

68,020

71,397

64,992

55,424

45,294

46,194

20,427

17,715

12,177

12,199

11,443

10,939

11,275

10,922

6,048

6,376

6,736

6,982

12,564

12,478

7,906

7,791

16,804

19,665

18,766

22,825

24,132

24,018

29,134

23,515

18,138

19,573

19,736

19,617

12,625

12,843

13,080

13,409

13,311

11,091

Deferred Long Term Liability

0
0
0
0
0
0
5,500
4,395
7,714
6,966
6,464
5,191
6,385
5,130
4,147
1,734
5,166
7,520
5,787
8,193
13,260
0
0
9,013
7,876
8,261
8,175
14,405
10,669
11,504
9,991
9,623
8,114
7,938
8,097
7,023
0
5,860
5,046
4,128
6,202
5,925
5,474
4,792
4,314
3,811
2,511
1,578
1,779
1,369
5,299
0
0

5,299

1,369

1,779

1,578

2,511

3,811

4,314

4,792

5,474

5,925

6,202

4,128

5,046

5,860

7,023

8,097

7,938

8,114

9,623

9,991

11,504

10,669

14,405

8,175

8,261

7,876

9,013

13,260

8,193

5,787

7,520

5,166

1,734

4,147

5,130

6,385

5,191

6,464

6,966

7,714

4,395

5,500

> Total Stockholder Equity

228,195
0
0
0
282,476
301,813
321,688
364,262
386,502
408,300
422,133
448,376
472,360
502,065
528,310
553,808
585,454
614,164
643,125
673,917
715,324
748,885
779,531
810,119
832,078
868,885
905,300
935,264
967,778
1,026,868
1,097,186
1,141,117
1,185,516
1,237,214
1,287,526
1,338,795
1,402,452
1,363,366
1,336,915
1,417,204
1,506,297
1,562,994
1,639,273
1,718,269
1,741,388
1,785,372
1,699,093
1,764,111
1,846,373
1,914,820
1,985,065
4,187,285
3,997,959

3,997,959

4,187,285

1,985,065

1,914,820

1,846,373

1,764,111

1,699,093

1,785,372

1,741,388

1,718,269

1,639,273

1,562,994

1,506,297

1,417,204

1,336,915

1,363,366

1,402,452

1,338,795

1,287,526

1,237,214

1,185,516

1,141,117

1,097,186

1,026,868

967,778

935,264

905,300

868,885

832,078

810,119

779,531

748,885

715,324

673,917

643,125

614,164

585,454

553,808

528,310

502,065

472,360

448,376

422,133

408,300

386,502

364,262

321,688

301,813

282,476

228,195

Common Stock

74
0
0
0
73
88
73
91
91
92
93
93
93
94
94
94
95
95
95
95
95
95
96
96
96
96
96
96
97
97
98
99
98
99
99
99
99
98
97
98
99
100
101
101
101
101
99
99
100
100
100
140
136

136

140

100

101

100

Retained Earnings

125,361
0
0
0
176,846
194,718
213,423
229,910
250,677
270,568
277,994
298,304
319,289
340,428
361,075
384,136
411,774
436,422
460,476
486,957
524,558
552,568
578,374
604,601
628,899
657,613
686,280
711,871
736,247
775,785
820,763
855,971
892,721
925,930
964,094
1,002,402
1,047,931
999,550
947,909
992,125
1,045,082
1,090,411
1,131,956
1,179,167
1,194,272
1,232,356
1,142,455
1,189,886
1,239,951
1,289,080
1,346,792
1,347,790
1,137,266

1,137,266

1,347,790

1,346,792

1,289,080

1,239,951

1,189,886

1,142,455

1,232,356

1,194,272

1,179,167

1,131,956

1,090,411

1,045,082

992,125

947,909

999,550

1,047,931

1,002,402

964,094

925,930

892,721

855,971

820,763

775,785

736,247

711,871

686,280

657,613

628,899

604,601

578,374

552,568

524,558

486,957

460,476

436,422

411,774

384,136

361,075

340,428

319,289

298,304

277,994

270,568

250,677

229,910

213,423

194,718

176,846

125,361

Capital Surplus

0
0
0
0
0
0
109,269
135,076
136,501
139,000
145,418
151,104
153,987
162,554
168,008
170,885
175,242
179,482
184,243
188,603
192,629
197,875
202,797
207,182
211,725
217,257
224,796
229,475
238,341
253,758
283,132
291,875
299,869
316,665
325,061
339,120
357,320
369,984
387,611
422,774
457,161
474,307
508,788
542,055
553,787
570,082
581,907
606,352
630,952
645,062
657,240
0
0

657,240

645,062

630,952

606,352

581,907

570,082

553,787

542,055

508,788

474,307

457,161

422,774

387,611

369,984

357,320

339,120

325,061

316,665

299,869

291,875

283,132

253,758

238,341

229,475

224,796

217,257

211,725

207,182

202,797

197,875

192,629

188,603

184,243

179,482

175,242

170,885

168,008

162,554

153,987

151,104

145,418

139,000

136,501

135,076

109,269

Treasury Stock

Other Stockholders Equity

0
0
0
0
106,708
107,908
109,269
135,076
136,501
139,000
145,418
151,104
153,987
162,554
168,008
170,885
175,242
179,482
184,243
188,603
192,629
197,875
202,797
207,182
211,725
217,257
224,796
229,475
238,341
253,758
283,132
291,875
299,869
316,665
325,061
339,120
357,320
369,984
387,611
422,774
457,161
474,307
508,788
542,055
553,787
570,082
581,907
606,352
630,952
645,062
657,240
2,858,091
2,870,749

2,870,749

2,858,091

657,240

645,062

630,952

606,352

581,907

570,082

553,787

542,055

508,788

474,307

457,161

422,774

387,611

369,984

357,320

339,120

325,061

316,665

299,869

291,875

283,132

253,758

238,341

229,475

224,796

217,257

211,725

207,182

202,797

197,875

192,629

188,603

184,243

179,482

175,242

170,885

168,008

162,554

153,987

151,104

145,418

139,000

136,501

135,076

109,269

107,908

106,708

Balance Sheet

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31
Accounts Payable	56,671	36,101	21,955	18,205	24,614	25,895	25,039	17,472	15,971	21,263	12,729	12,547	6,501	7,250	0	-
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Accumulated Other Comprehensive Income	-10,192	-24,630	-6,772	3,955	-2,898	-7,172	-6,907	-8,642	-1,958	-1,657	-1,009	-767	-1,202	-718	0	-
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Capital Lease Obligations	103,004	6,011	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Capital Stock	136	100	101	99	99	98	0	0	0	0	0	0	0	0	0	-
Capital Surpluse	0	630,952	553,787	457,161	357,320	299,869	238,341	211,725	192,629	0	153,987	136,501	0	0	0	-
Cash	467,292	150,466	193,069	239,397	195,724	139,747	118,817	132,639	60,152	82,265	89,962	212,400	142,668	111,701	0	-
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Cash And Short Term Investments	517,789	446,058	443,447	426,741	311,487	339,684	373,707	290,312	281,029	228,704	238,924	212,400	142,668	111,701	0	-
Common Stock	136	100	101	99	99	98	97	96	95	95	93	91	73	74	0	-
Common Stock Shares Outstanding	114,630	102,643	103,623	100,971	101,998	101,316	97,887	96,432	96,073	95,457	94,192	92,208	75,458	75,458	91,072	75,000
Common Stock Total Equity	0	100	101	99	99	98	97	96	95	95	93	91	73	74	0	-
Current Deferred Revenue	18,369	14,100	12,025	8,125	5,402	2,598	0	0	0	0	0	0	0	427	0	-
Deferred Long Term Asset Charges	0	0	0	0	0	13,578	20,031	30,638	0	0	0	0	0	0	0	-
Deferred Long Term Liab	0	1,779	4,314	6,202	0	8,114	10,669	7,876	0	0	6,385	7,714	0	0	0	-
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Good Will	1,434,540	197,471	179,708	156,716	128,775	123,734	123,890	105,926	91,964	53,196	18,372	15,372	9,808	0	0	-
Intangible Assets	924,603	63,574	68,660	86,949	78,812	87,323	78,659	61,706	33,242	34,529	29,537	9,585	7,433	0	0	-
Inventory	848,135	298,981	237,001	229,153	196,314	131,254	108,409	112,692	105,260	90,945	70,350	62,310	47,369	40,882	0	-
Liabilities And Stockholders Equity	5,086,083	2,076,126	1,957,263	1,679,485	1,532,077	1,300,670	1,078,502	927,637	834,100	703,547	566,304	447,133	329,390	266,575	0	-
Long Term Debt	417,400	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Long Term Debt Total	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Long Term Investments	75,428	495,852	562,475	358,522	409,514	263,117	56,133	60,444	48,762	75,347	36,528	0	0	0	0	-
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Net Debt	53,112	-144,455	-188,016	-234,596	-193,243	-139,747	-118,817	-132,639	-60,152	-82,265	-89,962	-212,400	-142,668	-106,448	0	-
Net Invested Capital	4,415,359	1,846,373	1,741,388	1,506,297	1,402,452	1,185,516	967,778	0	0	0	0	0	0	0	0	-
Net Receivables	504,870	217,308	165,651	148,100	162,424	144,356	127,060	95,783	86,353	81,202	65,137	58,601	50,063	48,583	0	-
Net Tangible Assets	0	1,585,328	1,493,020	1,262,632	1,194,865	974,459	765,229	664,446	590,118	497,729	424,451	361,545	0	0	0	-
Net Working Capital	1,523,027	824,140	724,352	700,973	576,065	534,563	527,269	433,874	462,108	380,613	348,866	320,602	229,504	187,245	0	-
Non Current Assets Total	3,170,709	1,092,782	1,092,747	857,720	844,609	669,989	458,160	413,871	289,301	233,522	149,496	87,023	70,615	47,603	0	-
Non Current Liabilities Other	102,919	68,770	71,397	46,194	12,199	10,922	6,982	7,791	22,825	0	19,617	13,409	0	0	0	-
Non Current Liabilities Total	695,777	70,549	75,711	52,396	18,222	19,036	17,651	15,667	36,085	28,681	26,002	21,123	17,643	6,653	0	-
Non Currrent Assets Other	78,590	43,311	36,334	32,039	21,741	10,364	36,280	30,928	-38,097	-39,087	-36,408	977	980	1,700	0	-
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Other Assets	0	92,156	60,828	209,832	25,186	23,942	56,311	61,566	590	975	909	977	980	1,700	0	-
Other Current Assets	44,580	20,997	18,417	17,771	17,243	15,387	11,166	14,502	7,351	5,742	5,080	3,020	2,515	2,273	0	-
Other Current Liab	305,340	106,467	11,770	5,777	6,727	63,115	68,034	62,420	66,720	68,149	55,213	26,961	22,770	18,797	0	-
Other Liab	0	70,549	75,711	52,396	17,080	19,036	17,651	15,667	36,085	23,515	19,617	13,409	11,888	3,845	0	-
Other Stockholder Equity	2,870,749	630,952	553,787	457,161	357,320	299,869	238,341	211,725	192,629	175,242	153,987	136,501	106,708	102,709	0	-
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	51	51	0	-
Property Plant And Equipment Gross	1,072,558	586,765	526,651	216,879	199,841	171,873	143,167	124,229	114,743	69,475	64,150	61,089	52,394	45,903	0	-
Property Plant And Equipment Net	646,863	243,729	221,076	216,879	199,841	171,873	143,167	124,229	114,743	69,475	64,150	61,089	52,394	45,903	0	-
Property Plant Equipment	0	243,729	221,076	216,879	202,322	171,873	143,167	124,229	114,743	69,475	64,150	61,089	52,394	45,903	0	-
Retained Earnings	1,137,266	1,239,951	1,194,272	1,045,082	1,047,931	892,721	736,247	628,899	524,558	411,774	319,289	250,677	176,846	126,079	0	-
Retained Earnings Total Equity	0	1,239,951	1,194,272	1,045,082	0	892,721	736,247	628,899	0	0	319,289	250,677	0	0	0	-
Short Long Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Short Long Term Debt Total	520,404	6,011	5,053	4,801	2,481	0	0	0	0	0	0	0	0	5,253	0	-
Short Term Debt	11,967	2,536	94,414	88,685	74,660	4,510	0	0	0	0	0	0	0	5,253	0	-
Short Term Investments	50,497	295,592	250,378	187,344	115,763	199,937	254,890	157,673	220,877	146,439	148,962	0	0	0	0	-
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Total Assets	5,086,083	2,076,126	1,957,263	1,679,485	1,532,077	1,300,670	1,078,502	927,637	834,100	703,547	566,304	447,133	329,390	266,575	0	-
Total Current Assets	1,915,374	983,344	864,516	821,765	687,468	630,681	620,342	513,766	544,799	470,025	416,808	360,110	258,775	218,972	0	-
Total Current Liabilities	392,347	159,204	140,164	120,792	111,403	96,118	93,073	79,892	82,691	89,412	67,942	39,508	29,271	31,727	0	-
Total Liab	1,088,124	229,753	215,875	173,188	129,625	115,154	110,724	95,559	118,776	118,093	93,944	60,631	46,914	38,380	0	-
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Total Stockholder Equity	3,997,959	1,846,373	1,741,388	1,506,297	1,402,452	1,185,516	967,778	832,078	715,324	585,454	472,360	386,502	282,476	228,195	0	-
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31
Accounts Payable	56,671	86,934	33,811	39,835	36,101	31,971	34,195	26,093	21,955	20,678	21,270	22,409	18,205	30,022	27,715	24,227	24,614	24,137	23,745	25,031	25,895	23,061	20,727	28,161	25,039	16,553	16,291	17,013	17,472	13,936	11,628	12,124	15,971	16,358	18,326	19,384	21,263	13,648	12,973	13,286	12,729	12,162	14,373	12,662	12,547	10,800	7,854	6,293	6,501	0	0	0	7,250
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Other Comprehensive Income	-10,192	-18,736	-19,067	-19,422	-24,630	-32,226	-25,368	-17,167	-6,772	-3,054	-1,572	-1,824	3,955	2,207	1,298	-6,266	-2,898	-2,826	-1,728	-5,480	-7,172	-6,828	-6,807	-2,772	-6,907	-6,178	-5,872	-6,081	-8,642	-1,760	-1,736	-1,653	-1,958	-1,738	-1,689	-1,835	-1,657	-1,307	-867	-1,011	-1,009	-1,125	-1,372	-1,360	-767	-815	-1,128	-901	-1,202	0	0	0	0
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	103,004	113,312	0	0	6,011	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Stock	136	140	100	100	100	99	99	101	101	101	101	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Surpluse	0	0	657,240	645,062	630,952	606,352	581,907	570,082	553,787	542,055	508,788	474,307	457,161	422,774	387,611	369,984	357,320	339,120	325,061	316,665	299,869	291,875	283,132	253,758	238,341	229,475	224,796	217,257	211,725	207,182	202,797	197,875	192,629	188,603	184,243	179,482	175,242	170,885	168,008	162,554	153,987	151,104	145,418	139,000	136,501	135,076	109,269	0	0	0	0	0	0
Cash	467,292	279,620	306,452	217,685	150,466	134,223	150,772	229,789	193,069	361,876	268,783	184,848	239,397	250,607	165,554	166,742	195,724	166,090	117,790	129,976	139,747	145,295	119,944	119,836	118,817	154,855	149,669	182,435	132,639	90,192	95,342	81,275	60,152	50,501	41,559	75,006	82,265	169,449	136,500	104,602	89,962	101,907	92,314	131,543	212,400	195,156	165,577	159,098	142,668	0	0	0	111,701
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash And Short Term Investments	517,789	468,934	612,828	504,370	446,058	405,286	408,010	473,294	443,447	553,195	460,427	403,559	426,741	409,637	316,735	276,953	311,487	277,492	240,427	320,664	339,684	372,761	360,920	369,177	373,707	337,659	312,189	326,098	290,312	257,919	324,512	318,131	281,029	238,602	199,806	213,280	228,704	298,751	276,265	280,806	238,924	213,146	161,158	162,328	212,400	195,156	165,577	159,098	142,668	0	0	0	0
Common Stock	136	140	100	100	100	99	99	101	101	101	101	100	99	98	97	98	99	99	99	99	98	99	98	97	97	96	96	96	96	96	96	95	95	95	95	95	95	94	94	94	93	93	93	92	91	91	73	88	73	0	0	0	74
Common Stock Shares Outstanding	139,021	115,245	101,782	102,196	102,209	101,417	102,884	104,077	104,192	104,418	103,475	102,420	101,414	100,485	97,509	102,146	102,933	102,100	101,582	101,367	101,627	101,804	101,510	100,496	98,726	97,849	97,818	97,148	96,513	96,492	96,426	96,293	96,214	96,119	96,049	95,905	95,670	95,475	95,480	95,172	94,629	94,422	93,970	93,573	93,456	92,697	90,388	75,657	88,063	90,398	74,652	75,657	0
Common Stock Total Equity	0	0	100	100	100	99	99	101	101	101	101	100	99	98	97	98	99	99	99	99	98	99	98	97	97	96	96	96	96	96	96	95	95	95	95	95	95	94	94	94	93	93	93	92	91	91	73	88	73	0	0	0	0
Current Deferred Revenue	18,369	17,992	14,945	13,541	14,100	12,286	13,185	11,807	12,025	9,667	9,005	8,653	8,125	6,179	6,513	6,452	5,402	4,129	3,385	2,788	2,598	1,878	2,089	1,579	20,031	0	0	0	30,638	0	0	0	38,687	0	0	0	40,062	0	0	0	37,317	0	0	0	23,779	0	0	0	0	0	0	0	0
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6,688	0	8,737	11,978	12,350	13,578	15,391	17,816	20,474	20,031	36,127	34,974	33,104	30,638	28,295	24,086	25,323	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Long Term Liab	0	0	5,299	1,369	1,779	1,578	2,511	3,811	4,314	4,792	5,474	5,925	6,202	4,128	5,046	5,860	0	7,023	8,097	7,938	8,114	9,623	9,991	11,504	10,669	14,405	8,175	8,261	7,876	9,013	0	0	13,260	8,193	5,787	7,520	5,166	1,734	4,147	5,130	6,385	5,191	6,464	6,966	7,714	4,395	5,500	0	0	0	0	0	0
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Good Will	1,434,540	1,122,428	198,932	198,710	197,471	181,774	182,702	179,045	179,708	166,578	155,777	155,373	156,716	129,662	129,184	128,952	128,775	129,004	129,901	123,680	123,734	124,015	123,750	124,780	123,890	119,273	112,769	106,215	105,926	110,250	91,964	91,964	91,964	91,964	93,561	93,573	53,196	18,372	18,372	18,372	18,372	15,372	15,372	15,372	15,372	15,342	9,808	9,808	9,808	0	0	0	0
Intangible Assets	924,603	1,261,617	54,901	59,194	63,574	54,057	59,131	64,385	68,660	73,095	76,153	80,414	86,949	81,794	85,226	88,691	78,812	81,969	85,465	84,269	87,323	89,522	74,973	78,935	78,659	87,653	90,036	61,343	61,706	67,438	32,993	32,849	33,242	33,635	33,951	34,342	34,529	29,139	29,271	29,404	29,537	9,189	9,321	9,453	9,585	9,746	7,238	7,324	7,433	0	0	0	0
Inventory	848,135	904,977	335,556	321,033	298,981	282,408	266,043	253,886	237,001	234,368	231,208	232,007	229,153	231,858	224,457	208,451	196,314	187,060	173,040	143,380	131,254	124,372	114,758	107,580	108,409	111,462	111,108	113,037	112,692	115,606	104,417	105,147	105,260	105,705	101,046	98,947	90,945	77,430	76,362	72,507	70,350	71,199	71,356	66,867	62,310	57,038	53,122	49,271	47,369	0	0	0	40,882
Liabilities And Stockholders Equity	5,086,083	5,355,875	2,212,465	2,149,620	2,076,126	1,976,512	1,914,712	1,998,694	1,957,263	1,910,578	1,830,213	1,737,890	1,679,485	1,541,739	1,465,802	1,479,365	1,532,077	1,452,182	1,390,746	1,335,919	1,300,670	1,238,506	1,193,833	1,127,660	1,078,502	1,037,160	995,014	960,421	927,637	901,743	869,476	839,988	834,100	800,661	764,663	744,129	703,547	646,439	618,000	599,422	566,304	524,672	498,075	473,620	447,133	416,042	367,304	354,809	329,390	0	0	0	0
Long Term Debt	417,400	409,723	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	803	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Debt Total	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments	75,428	275,958	391,521	480,025	495,852	503,965	473,663	546,881	562,475	431,814	453,726	434,877	358,522	275,587	319,483	380,061	409,514	383,099	369,665	300,802	263,117	194,683	182,526	131,899	84,466	88,051	90,932	93,066	90,444	64,451	65,625	58,943	48,762	61,525	81,380	71,513	75,347	47,028	36,754	24,151	36,528	50,653	70,517	61,788	0	0	0	0	0	0	0	0	0
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Debt	53,112	243,415	-306,452	-217,685	-144,455	-134,223	-150,772	-229,789	-193,069	-361,876	-268,783	-184,848	-239,397	-250,607	-165,554	-166,742	-195,724	-166,090	-117,790	-129,976	-139,747	-145,295	-119,944	-119,836	-118,817	-154,855	-149,669	-182,435	-132,639	-90,192	-95,342	-81,275	-60,152	-50,501	-41,559	-75,006	-82,265	-169,449	-136,500	-104,602	-89,962	-101,907	-92,314	-131,543	-212,400	-195,156	-165,577	-159,098	-142,668	0	0	0	0
Net Invested Capital	4,415,359	4,597,008	1,985,065	1,914,820	1,846,373	1,764,111	1,699,093	1,785,372	1,741,388	1,718,269	1,639,273	1,562,994	1,506,297	1,417,204	1,336,915	1,363,366	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Receivables	504,870	495,852	241,942	225,825	217,308	208,504	198,536	169,831	165,651	176,744	185,163	162,675	148,100	151,365	136,074	138,683	162,424	157,576	156,954	140,609	144,356	135,317	140,603	125,170	127,060	105,011	105,475	94,279	95,783	92,603	89,845	75,808	86,353	85,591	79,966	73,703	81,202	64,699	69,744	64,366	65,137	61,934	71,581	64,971	58,601	58,209	53,287	54,220	50,063	0	0	0	0
Net Tangible Assets	0	1,803,240	1,731,232	1,656,916	1,585,328	1,528,280	1,457,260	1,541,942	1,493,020	1,478,596	1,407,343	1,327,207	1,262,632	1,205,748	1,122,505	1,145,723	1,194,865	1,127,822	1,072,160	1,029,265	974,459	927,580	898,463	823,153	765,229	728,338	702,495	701,327	664,446	632,431	654,574	624,072	590,118	548,318	515,613	486,249	497,729	506,297	480,667	454,289	424,451	423,815	397,440	383,475	361,545	339,174	304,591	0	0	0	0	0	0
Net Working Capital	1,523,027	1,488,615	1,054,790	902,882	824,140	774,746	745,151	775,107	724,352	857,989	761,956	690,696	700,973	711,971	590,765	543,838	576,065	542,142	499,749	538,076	534,563	564,683	552,944	532,373	527,269	488,635	466,068	465,530	433,874	412,403	465,149	443,161	462,108	411,889	363,023	362,384	380,613	412,054	401,130	388,410	348,866	326,284	281,247	278,161	320,602	299,358	264,743	246,657	229,504	0	0	0	0
Non Current Assets Total	3,170,709	3,438,538	1,002,455	1,079,191	1,092,782	1,056,511	1,023,544	1,082,096	1,092,747	930,064	938,215	923,517	857,720	729,788	768,911	837,565	844,609	815,119	806,813	718,351	669,989	592,105	560,609	512,735	458,160	473,598	459,885	419,522	413,871	423,533	334,047	324,490	289,301	294,353	309,907	288,434	233,522	161,626	150,900	138,521	149,496	139,908	160,193	150,185	87,023	82,610	73,536	72,065	70,615	0	0	0	0
Non Current Liabilities Other	102,919	98,027	66,881	65,884	68,770	65,568	67,091	68,020	71,397	64,992	55,424	45,294	46,194	20,427	17,715	12,177	12,199	11,443	10,939	11,275	10,922	6,048	6,376	6,736	6,982	12,564	12,478	7,906	7,791	16,804	19,665	18,766	22,825	24,132	24,018	29,134	23,515	18,138	19,573	19,736	19,617	12,625	12,843	13,080	13,409	13,311	11,091	0	0	0	0	0	0
Non Current Liabilities Total	695,777	739,868	72,180	67,253	70,549	67,146	69,602	71,831	75,711	69,784	60,898	51,219	52,396	24,555	22,761	18,037	18,222	18,466	19,036	19,213	19,036	15,671	16,367	18,240	17,651	26,969	20,653	16,167	15,667	25,817	19,665	18,766	36,085	32,325	29,805	36,654	28,681	19,872	23,720	24,866	26,002	17,816	19,307	20,046	21,123	17,706	16,591	16,909	17,643	0	0	0	0
Non Currrent Assets Other	78,590	69,478	47,215	44,985	43,311	35,654	34,007	34,307	36,334	33,574	33,147	28,693	32,039	22,851	21,070	20,568	21,741	15,212	15,671	12,962	10,364	32,559	33,869	34,954	36,280	37,447	31,051	30,954	30,928	26,015	302	306	590	-42,869	-41,343	-40,251	975	-36,725	-38,386	-37,527	909	-31,319	-27,282	-23,872	977	630	718	852	980	0	0	0	0
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	0	75,484	109,053	0	92,156	80,373	69,166	64,244	60,828	42,912	41,810	36,667	209,832	23,216	19,072	23,822	25,186	21,820	25,674	23,368	23,942	47,950	51,685	55,428	314,993	339,384	329,762	294,682	289,642	296,449	214,970	209,385	174,558	188,173	209,994	200,518	164,047	95,564	85,328	72,878	85,346	76,294	96,259	87,652	25,934	25,718	17,764	17,984	18,221	0	0	0	1,700
Other Current Assets	44,580	47,574	19,684	19,201	20,997	23,803	18,579	19,587	18,417	16,207	15,200	16,132	17,771	19,091	19,625	17,713	17,243	14,835	13,512	12,915	15,387	13,951	16,943	12,998	11,166	9,430	5,879	7,008	14,502	11,605	5,420	5,961	7,351	7,107	6,811	5,054	5,742	6,183	5,412	4,744	5,080	6,086	5,456	4,358	3,020	23,029	21,782	20,155	2,515	0	0	0	17,806
Other Current Liab	305,340	310,411	104,706	114,171	106,467	100,998	98,637	103,591	11,770	8,729	8,182	6,048	5,777	997	665	6,333	6,727	5,603	6,016	2,000	6,830	6,693	6,507	6,659	12,166	58,374	52,770	58,356	14,108	51,871	58,652	60,213	12,188	78,061	73,407	73,927	6,081	59,111	52,997	59,205	1,730	46,318	42,262	32,612	1,435	23,274	21,171	29,794	22,770	0	0	0	18,797
Other Liab	0	229,549	72,180	0	70,549	67,146	69,602	71,831	75,711	69,784	60,898	51,219	52,396	21,945	20,437	16,262	17,080	17,595	18,296	18,410	19,036	15,671	16,367	18,240	6,982	12,564	12,478	7,906	7,791	16,804	19,665	18,766	22,825	24,132	24,018	29,134	23,515	18,138	19,573	19,736	19,617	12,625	12,843	13,080	13,409	13,311	11,091	11,603	11,888	0	0	0	3,845
Other Stockholder Equity	2,870,749	2,858,091	657,240	645,062	630,952	606,352	581,907	570,082	553,787	542,055	508,788	474,307	457,161	422,774	387,611	369,984	357,320	339,120	325,061	316,665	299,869	291,875	283,132	253,758	238,341	229,475	224,796	217,257	211,725	207,182	202,797	197,875	192,629	188,603	184,243	179,482	175,242	170,885	168,008	162,554	153,987	151,104	145,418	139,000	136,501	135,076	109,269	107,908	106,708	0	0	0	0
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	51	51	51	0	0	0	51
Property Plant And Equipment Gross	1,072,558	1,089,558	612,263	598,966	586,765	569,259	0	0	0	0	210,749	216,186	216,879	215,274	211,902	212,605	199,841	197,098	194,133	184,288	171,873	161,768	154,342	149,193	143,167	134,214	130,123	124,840	124,229	127,084	119,077	115,105	114,743	106,180	99,913	87,916	69,475	66,062	65,572	65,643	64,150	63,614	63,934	62,533	61,089	56,892	55,772	54,081	52,394	0	0	0	0
Property Plant And Equipment Net	646,863	701,742	248,048	245,098	243,729	236,342	238,882	227,541	221,076	215,665	210,749	216,186	216,879	215,274	211,902	212,605	199,841	197,098	194,133	184,288	171,873	161,768	154,342	149,193	143,167	134,214	130,123	124,840	124,229	127,084	119,077	115,105	114,743	106,180	99,913	87,916	69,475	66,062	65,572	65,643	64,150	63,614	63,934	62,533	61,089	56,892	55,772	54,081	52,394	0	0	0	0
Property Plant Equipment	0	703,051	248,048	245,098	243,729	236,342	238,882	227,541	221,076	215,665	210,749	216,186	216,879	215,274	211,902	212,605	202,322	199,227	194,133	184,288	171,873	161,768	154,342	149,193	143,167	134,214	130,123	124,840	124,229	127,084	119,077	115,105	114,743	106,180	99,913	87,916	69,475	66,062	65,572	65,643	64,150	63,614	63,934	62,533	61,089	56,892	55,772	54,081	52,394	0	0	0	45,903
Retained Earnings	1,137,266	1,347,790	1,346,792	1,289,080	1,239,951	1,189,886	1,142,455	1,232,356	1,194,272	1,179,167	1,131,956	1,090,411	1,045,082	992,125	947,909	999,550	1,047,931	1,002,402	964,094	925,930	892,721	855,971	820,763	775,785	736,247	711,871	686,280	657,613	628,899	604,601	578,374	552,568	524,558	486,957	460,476	436,422	411,774	384,136	361,075	340,428	319,289	298,304	277,994	270,568	250,677	229,910	213,423	194,718	176,846	0	0	0	125,361
Retained Earnings Total Equity	0	0	1,346,792	1,289,080	1,239,951	1,189,886	1,142,455	1,232,356	1,194,272	1,179,167	1,131,956	1,090,411	1,045,082	992,125	947,909	999,550	0	1,002,402	964,094	925,930	892,721	855,971	820,763	775,785	736,247	711,871	686,280	657,613	628,899	604,601	578,374	552,568	524,558	486,957	460,476	436,422	411,774	384,136	361,075	340,428	319,289	298,304	277,994	270,568	250,677	229,910	213,423	0	0	0	0	0	0
Short Long Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,141	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt Total	520,404	523,035	0	0	6,011	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Term Debt	11,967	13,385	1,758	0	2,536	0	0	0	94,414	83,451	91,585	86,567	88,685	62,782	71,233	60,950	74,660	61,052	51,038	49,673	60,795	50,086	50,957	46,153	35,837	0	0	0	17,674	0	0	0	15,845	0	0	0	22,006	0	0	0	16,166	0	0	0	1,747	0	0	0	0	0	0	0	0
Short Term Investments	50,497	189,314	306,376	286,685	295,592	271,063	257,238	243,505	250,378	191,319	191,644	218,711	187,344	159,030	151,181	110,211	115,763	111,402	122,637	190,688	199,937	227,466	240,976	249,341	254,890	182,804	162,520	143,663	157,673	167,727	229,170	236,856	220,877	188,101	158,247	138,274	146,439	129,302	139,765	176,204	148,962	111,239	68,844	30,785	0	0	0	0	0	0	0	0	0
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	5,086,083	5,355,875	2,212,465	2,149,620	2,076,126	1,976,512	1,914,712	1,998,694	1,957,263	1,910,578	1,830,213	1,737,890	1,679,485	1,541,739	1,465,802	1,479,365	1,532,077	1,452,182	1,390,746	1,335,919	1,300,670	1,238,506	1,193,833	1,127,660	1,078,502	1,037,160	995,014	960,421	927,637	901,743	869,476	839,988	834,100	800,661	764,663	744,129	703,547	646,439	618,000	599,422	566,304	524,672	498,075	473,620	447,133	416,042	367,304	354,809	329,390	0	0	0	266,575
Total Current Assets	1,915,374	1,917,337	1,210,010	1,070,429	983,344	920,001	891,168	916,598	864,516	980,514	891,998	814,373	821,765	811,951	696,891	641,800	687,468	637,063	583,933	617,568	630,681	646,401	633,224	614,925	620,342	563,562	535,129	540,899	513,766	478,210	535,429	515,498	544,799	506,308	454,756	455,695	470,025	484,813	467,100	460,901	416,808	384,764	337,882	323,435	360,110	333,432	293,768	282,744	258,775	0	0	0	0
Total Current Liabilities	392,347	428,722	155,220	167,547	159,204	145,255	146,017	141,491	140,164	122,525	130,042	123,677	120,792	99,980	106,126	97,962	111,403	94,921	84,184	79,492	96,118	81,718	80,280	82,552	93,073	74,927	69,061	75,369	79,892	65,807	70,280	72,337	82,691	94,419	91,733	93,311	89,412	72,759	65,970	72,491	67,942	58,480	56,635	45,274	39,508	34,074	29,025	36,087	29,271	0	0	0	31,727
Total Liab	1,088,124	1,168,590	227,400	234,800	229,753	212,401	215,619	213,322	215,875	192,309	190,940	174,896	173,188	124,535	128,887	115,999	129,625	113,387	103,220	98,705	115,154	97,389	96,647	100,792	110,724	101,896	89,714	91,536	95,559	91,624	89,945	91,103	118,776	126,744	121,538	129,965	118,093	92,631	89,690	97,357	93,944	76,296	75,942	65,320	60,631	51,780	45,616	52,996	46,914	0	0	0	38,380
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Stockholder Equity	3,997,959	4,187,285	1,985,065	1,914,820	1,846,373	1,764,111	1,699,093	1,785,372	1,741,388	1,718,269	1,639,273	1,562,994	1,506,297	1,417,204	1,336,915	1,363,366	1,402,452	1,338,795	1,287,526	1,237,214	1,185,516	1,141,117	1,097,186	1,026,868	967,778	935,264	905,300	868,885	832,078	810,119	779,531	748,885	715,324	673,917	643,125	614,164	585,454	553,808	528,310	502,065	472,360	448,376	422,133	408,300	386,502	364,262	321,688	301,813	282,476	0	0	0	228,195
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flow

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31
Begin Period Cash Flow	150,466	193,069	239,397	195,724	139,747	118,817	66,954	60,152	82,265	89,962	212,400	142,668	111,701	50,650	44,722
Capital Expenditures	78,274	74,047	56,898	63,658	70,750	59,697	51,303	40,909	50,760	24,754	23,680	24,684	22,487	12,303	25,963
Cash And Cash Equivalents Changes	0	-41,856	-45,518	42,808	0	20,930	51,863	72,487	-22,113	-7,697	-122,438	69,732	0	0	0
Cash Flows Other Operating	0	-12,939	-6,388	-11,788	0	-7,496	-4,297	30,209	-3,952	-23,619	-597	2	0	0	0
Change In Cash	316,826	-42,603	-46,328	43,673	55,977	20,930	51,863	72,487	-22,113	-7,697	-122,438	69,732	30,967	61,051	5,928
Change In Working Capital	-116,598	-105,262	-17,252	-37,590	-73,444	-49,868	-30,522	3,485	-43,478	-47,759	6,238	-20,577	-17,292	-10,661	-39,747
Change Receivables	0	-50,843	-25,895	10,696	0	-21,789	-24,955	-4,668	-4,193	-12,667	-9,612	-6,886	0	0	0
Change To Account Receivables	-49,914	-50,843	-25,895	10,696	-18,306	-21,789	-24,955	-4,668	-4,193	-12,667	-9,612	-6,886	-4,672	-6,560	-11,963
Change To Inventory	-70,328	-61,745	-11,971	-50,111	-50,018	-31,382	-5,277	-10,503	-19,327	-18,001	-16,678	-20,541	-15,280	-10,188	-18,478
Change To Liabilities	0	17,618	26,792	12,913	773	10,799	9,843	-23	-16,006	6,528	33,125	6,967	0	0	0
Change To Netincome	0	22,567	71,897	71,337	37,475	31,730	40,642	26,867	25,330	10,012	-776	5,038	0	0	0
Change To Operating Activities	0	-4,205	11,718	6,520	-5,220	7,232	-6,838	-13,596	-4,830	-18,470	0	0	0	0	0
Depreciation	144,733	68,252	69,867	62,874	52,734	41,630	42,067	38,771	24,084	21,754	19,397	18,108	16,949	15,196	13,502
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
End Period Cash Flow	467,292	150,466	193,069	239,397	195,724	139,747	118,817	132,639	60,152	82,265	89,962	212,400	142,668	111,701	50,650
Exchange Rate Changes	0	0	0	0	0	-256	1,979	-1,894	153	185	230	-97	0	0	0
Free Cash Flow	165,225	104,421	219,376	135,135	101,225	121,946	108,232	130,984	71,197	54,418	69,791	51,835	53,923	58,985	6,116
Investments	-78,131	-4,880	-284,553	-20,181	-45,732	-123,505	-111,277	-99,553	-53,777	-39,118	-186,695	0	0	0	0
Issuance Of Capital Stock	0	0	63,496	72,322	31,036	39,309	0	0	0	0	0	0	0	0	0
Net Borrowings	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	122,873	190,169	149,191	102,285	155,210	156,474	107,348	104,341	112,784	92,485	68,612	73,831	60,784	54,458	52,033
Other Cashflows From Financing Activities	-18,656	-7,185	-9,349	-6,316	-6,597	-6,739	-10,109	-3,833	850	3,208	3,456	1,561	-346	787	1,107
Other Cashflows From Investing Activities	0	-31,435	-34,488	-33,483	-69,531	-9,825	30,000	-30,000	-102,290	-36,128	-16,775	-6,031	0	0	0
Other Non Cash Items	97,538	14,722	61,497	48,489	7,088	10,537	17,664	17,724	12,693	9,960	8,905	6,601	10,626	6,271	5,434
Sale Purchase Of Stock	-225,562	-144,493	63,496	-104,669	31,036	39,309	11,735	5,874	5,477	9,738	7,555	1,504	-10,021	0	0
Stock Based Compensation	52,742	32,810	30,586	27,073	26,085	21,899	14,686	11,382	9,639	7,111	5,177	4,635	3,286	4,025	3,511
Total Cash From Financing Activities	-231,821	-109,962	54,147	-38,663	24,439	32,570	1,626	2,041	6,327	12,946	11,011	24,025	-14,734	1,768	1,494
Total Cash From Operating Activities	243,499	178,468	276,274	198,793	171,975	181,643	159,535	171,893	121,957	79,172	93,471	76,519	76,410	71,288	32,079
Total Cashflows From Investing Activities	0	-110,362	-375,939	-117,322	-140,281	-193,027	-111,277	-162,738	-153,050	-100,000	-227,150	-30,715	0	0	0

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31
Begin Period Cash Flow	279,620	306,452	217,685	150,466	134,223	150,772	229,789	193,069	361,876	268,783	184,848	239,397	250,607	165,554	166,742	195,724	166,190	117,790	129,976	139,747	145,295	119,944	119,836	118,817	154,855	149,669	182,435	132,639	90,192	95,342	81,275	60,152	50,501	41,559	75,006	82,265	169,449	136,500	104,602	89,962	101,907	92,314	131,543	212,400	195,156	165,577	159,098	142,668	127,329	107,752	110,851	111,701	0
Capital Expenditures	22,881	21,534	17,868	15,991	18,340	11,983	23,753	19,971	17,045	17,795	8,386	13,672	14,063	17,325	9,956	22,314	15,793	12,062	14,740	28,155	17,159	15,371	14,793	12,374	13,425	12,817	13,528	11,533	14,208	6,559	10,776	9,366	14,154	11,480	17,898	7,228	9,095	3,428	6,067	6,164	5,205	5,519	6,184	6,772	7,652	5,183	5,536	6,313	6,793	3,645	6,098	5,951	12,303
Cash And Cash Equivalents Changes	0	0	88,334	67,245	17,082	-17,028	-78,753	36,843	-168,567	93,055	83,974	-53,980	-11,696	84,592	-1,106	-28,982	0	48,400	-12,186	-9,771	-5,548	25,351	108	1,019	29,647	5,186	-32,766	49,796	42,447	-5,150	14,067	21,123	9,651	8,942	-33,447	-7,259	-87,184	32,949	31,898	14,640	-11,945	9,593	-39,229	-80,857	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	0	0	-3,654	64	-4,052	-9,056	365	-196	-5,594	-1,639	-3,671	4,516	-6,707	-2,206	-2,670	-205	0	-111	-3,781	848	-7,415	3,222	-2,069	-1,234	-3,800	-9,002	-123	8,628	-2,765	16,976	-879	16,877	-569	-1,174	-3,105	896	-22,294	-941	-623	239	1,514	-365	-896	-850	0	0	0	0	0	0	0	0	0
Change In Cash	187,672	-26,832	88,767	67,219	16,243	-16,549	-79,017	36,720	-168,807	93,093	83,935	-54,549	-11,210	85,053	-1,188	-28,982	29,534	48,400	-12,186	-9,771	-5,548	25,351	108	1,019	-36,038	5,186	-32,766	49,796	42,447	-5,150	14,067	21,123	9,651	8,942	-33,447	-7,259	-87,184	32,949	31,898	14,640	-11,945	9,593	-39,229	-80,857	17,244	29,579	6,479	16,430	15,339	19,577	-3,099	-850	0
Change In Working Capital	-45,400	-1,593	-48,497	-21,108	-14,903	-32,985	-40,080	-17,294	12,435	5,302	-26,672	-8,317	-3,395	-16,503	-13,388	-4,304	-15,900	-4,849	-36,450	-16,245	-11,698	-3,359	-28,444	-6,367	-4,439	-13,782	-19,753	7,452	970	5,286	-17,215	14,444	-17,225	-8,681	-18,790	1,218	-36,238	3,899	-16,802	1,382	6,629	9,246	-1,946	-7,691	-6,712	960	-13,583	-1,242	-2,112	-1,536	-15,659	2,015	0
Change Receivables	0	0	-18,376	-9,861	-4,643	-15,976	-28,610	-1,614	-5,967	5,659	-5,241	-20,346	2,284	-10,894	5,175	14,131	0	1,165	-3,999	-2,533	-18,889	-643	2,823	-5,080	-22,755	972	-947	-2,225	-7,779	487	423	2,201	-725	-5,059	-297	1,888	-11,781	1,605	-1,679	-812	-7,469	2,267	1,787	-6,197	0	0	0	0	0	0	0	0	0
Change To Account Receivables	-12,961	-8,716	-18,376	-9,861	-4,643	-15,976	-28,610	-1,614	-5,967	5,659	-5,241	-20,346	2,284	-10,894	5,175	14,131	-12,939	1,165	-3,999	-2,533	-18,889	-643	2,823	-5,080	-22,755	972	-947	-2,225	-7,779	487	423	2,201	-725	-5,059	-297	1,888	-11,781	1,605	-1,679	-812	-7,469	2,267	1,787	-6,197	-1,609	-2,227	1,135	-4,185	-3,804	-889	-164	185	0
Change To Inventory	-11,350	-20,320	-16,188	-22,470	-13,095	-17,229	-13,482	-17,939	-2,810	-3,137	-2,027	-3,997	-2,840	-12,900	-22,263	-12,108	-9,149	-12,775	-14,250	-13,844	-8,340	-11,922	-9,914	-1,206	1,679	-2,304	-2,550	-2,102	-3,894	-2,797	-1,560	-2,252	-2,329	-5,347	-4,290	-7,361	-5,466	-3,041	-5,501	-3,993	-963	-2,760	-5,946	-7,009	-5,954	-5,258	-5,599	-3,730	-4,236	-4,952	-2,770	-3,322	0
Change To Liabilities	0	-5,183	-10,997	10,387	6,261	8,354	1,291	1,712	26,596	4,419	-1,475	11,510	3,868	8,797	6,370	-6,122	931	6,872	-14,420	-716	22,946	5,984	-19,284	1,153	20,437	-3,448	-16,133	3,151	15,408	-9,380	-15,199	-2,382	-13,602	2,899	-11,098	5,795	3,303	6,276	-8,999	5,948	13,547	10,104	3,109	6,365	0	0	0	0	0	0	0	0	0
Change To Netincome	0	13,691	8,152	7,474	11,586	581	4,284	6,116	31,075	7,366	25,186	8,881	13,346	9,823	42,108	6,060	10,634	9,105	8,364	10,380	7,434	9,147	6,286	8,863	16,193	12,223	5,520	4,035	8,392	1,601	5,761	4,964	16,287	5,174	1,262	2,490	4,241	2,805	1,552	1,414	-142	-858	-1,242	1,466	0	0	0	0	0	0	0	0	0
Change To Operating Activities	0	22,287	6,145	6,145	1,001	934	8,741	-14,881	5,012	2,302	4,671	-267	7,152	9,999	3,276	-13,907	-3,401	9,858	-2,541	-9,136	9,278	3,361	2,899	-8,306	-6,361	-13,882	5,550	8,628	12,045	16,976	-879	0	-4,830	0	0	0	-18,470	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	71,162	37,388	18,075	18,108	16,910	17,578	16,927	16,837	16,829	16,751	19,130	17,157	16,904	16,301	15,101	14,568	14,046	13,575	12,859	12,254	11,936	10,461	9,757	9,476	8,294	10,838	10,695	12,240	17,235	7,838	7,022	6,676	6,415	6,090	5,905	5,674	5,697	5,373	5,387	5,297	5,186	4,859	4,742	4,610	4,608	4,612	4,507	4,381	4,747	4,326	4,055	3,821	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
End Period Cash Flow	467,292	279,620	306,452	217,685	150,466	134,223	150,772	229,789	193,069	361,876	268,783	184,848	239,397	250,607	165,554	166,742	195,724	166,190	117,790	129,976	139,747	145,295	119,944	119,836	118,817	154,855	149,669	182,435	132,639	90,192	95,342	81,275	60,152	50,501	41,559	75,006	82,265	169,449	136,500	104,602	89,962	101,907	92,314	131,543	212,400	195,156	165,577	159,098	142,668	127,329	107,752	110,851	111,701
Exchange Rate Changes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-16	0	-417	226	-40	-60	-125	-1,042	971	1,201	328	129	321	430	-2,443	28	91	36	82	-6	41	140	162	-61	-56	32	163	-3	38	0	0	0	0	0	0	0	0	0
Free Cash Flow	81,793	28,950	17,160	37,322	45,635	20,937	13,130	24,719	59,208	59,467	50,803	49,898	66,121	35,923	13,112	19,979	38,516	43,804	7,857	11,048	27,132	36,417	18,476	39,921	31,412	22,456	12,448	41,916	37,688	35,375	12,240	45,681	29,926	18,566	-4,737	27,442	-7,150	32,217	6,283	23,068	27,453	28,038	2,796	11,504	11,798	17,006	6,493	16,538	15,859	19,681	1,772	16,611	58,985
Investments	320,615	234,039	70,090	29,645	-11,884	-51,127	51,054	7,077	-192,264	10,910	8,243	-111,442	-103,537	34,986	28,648	19,722	-36,035	-1,606	2,136	-25,684	-36,458	333	-43,640	-43,740	-4,440	-18,630	-17,530	10,570	7,800	36,413	-35	-26,754	-21,252	-10,863	-30,626	11,464	-46,204	-346	22,245	-14,813	-23,926	-22,607	-46,975	-93,187	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	0	0	0	0	0	0	0	0	3,563	24,336	26,496	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	15,034	998	57,712	49,129	50,065	47,430	54,590	38,084	15,106	47,211	41,545	45,329	52,957	44,216	-20,837	25,949	45,529	38,307	38,164	33,210	36,750	35,208	44,978	39,538	24,376	25,591	28,667	28,714	24,298	26,227	25,806	28,010	37,601	26,481	24,054	24,648	27,638	23,061	20,647	21,139	20,985	20,310	7,426	19,891	20,767	16,487	19,001	17,576	13,570	16,863	15,920	14,431	54,458
Other Cashflows From Financing Activities	-12,748	-1,874	-2,115	-1,919	-28,125	-1,735	1,731	6,047	-4,586	-1,658	-1,568	-1,537	-989	-4,474	-287	-566	-501	-463	-283	-5,350	-226	-563	-510	-5,440	-4,875	-31,447	-233	-5,001	-4,917	720	154	210	-223	356	333	384	64	-97	655	2,586	-63	2,032	1,584	-97	5,005	-2,901	-267	-276	-400	30	21	3	0
Other Cashflows From Investing Activities	0	0	0	-2,662	-30,260	0	-175	-1,000	-34,488	0	0	0	-1,492	-10,000	-21,991	19,722	-69,531	-49,289	-24,135	-25,684	1,000	-13,825	3,000	30,000	1,557	0	-31,501	0	-30,000	-76,068	0	0	-30,000	-497	-1	-48,015	-36,128	0	0	0	-16,775	0	0	0	0	0	0	0	0	0	0	0	0
Other Non Cash Items	63,232	25,766	6,330	2,210	8,605	1,658	2,554	1,905	38,562	1,895	18,529	2,511	7,663	5,545	33,113	2,168	2,328	925	1,358	2,477	3,117	3,756	-55	3,719	5,102	3,976	4,635	3,951	8,902	2,817	3,249	2,756	4,235	2,958	2,284	3,216	2,212	2,535	3,311	1,902	2,266	3,087	1,498	2,054	856	1,770	2,001	1,974	3,445	2,829	2,675	1,677	0
Sale Purchase Of Stock	-225,562	0	3,199	4,859	15,488	14,897	-144,493	7,746	3,563	24,336	26,496	9,101	104,669	-104,669	-30,805	-73,864	31,036	7,082	2,013	10,255	3,064	3,114	23,824	9,307	4,792	1,032	3,921	1,990	1,446	853	1,680	1,895	1,164	1,298	1,590	1,425	2,094	1,013	2,776	3,855	1,334	1,967	3,369	885	1,504	0	0	0	-21	0	0	-10,000	0
Stock Based Compensation	12,445	22,755	8,589	8,953	8,507	8,314	7,837	8,152	7,805	7,451	7,632	7,698	5,935	7,020	7,311	6,807	6,438	6,898	6,301	6,448	4,821	5,545	5,480	6,053	4,027	3,597	3,571	3,491	2,945	2,747	2,920	2,770	2,704	2,266	2,538	2,131	1,900	1,661	1,623	1,927	1,312	1,387	1,166	1,312	953	1,545	1,026	1,111	1,135	765	585	801	0
Total Cash From Financing Activities	-237,270	1,425	1,084	2,940	13,591	13,162	-142,762	6,047	-1,023	22,678	24,928	7,564	27,212	23,683	-20,891	-68,667	11,185	6,619	1,730	4,905	2,838	2,551	23,314	3,867	-83	1,032	3,688	-3,011	-3,471	1,573	1,834	2,105	941	1,654	1,923	1,809	2,158	916	3,431	6,441	1,271	3,999	4,953	788	5,460	18,628	125	-188	-80	214	-4,950	-9,918	1,768
Total Cash From Operating Activities	104,674	50,484	35,028	53,313	63,975	32,920	36,883	44,690	76,253	77,262	59,189	63,570	80,184	53,248	23,068	42,293	54,309	55,866	22,597	39,203	44,291	51,788	33,269	52,295	44,837	35,273	25,976	53,449	51,896	41,934	23,016	55,047	44,080	30,046	13,161	34,670	1,945	35,645	12,350	29,232	32,658	33,557	8,980	18,276	19,450	22,189	12,029	22,851	22,652	23,326	7,870	22,562	71,288
Total Cashflows From Investing Activities	0	-80,861	52,222	10,992	-60,484	-63,110	27,126	-13,894	-243,797	-6,885	-143	-125,114	-119,092	7,661	-3,299	-2,592	-36,035	-13,668	-36,739	-53,839	-52,617	-28,863	-55,433	-56,114	-16,308	-31,447	-62,559	-963	-6,408	-46,214	-10,811	-36,120	-35,406	-22,840	-48,525	-43,779	-100,000	-3,774	16,178	-20,977	-45,906	-28,126	-53,159	-99,959	-30,715	-23,063	0	0	0	0	0	0	0

Income Statement

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31
Cost Of Revenue	548,174	263,725	239,223	217,463	179,975	159,410	150,453	134,705	132,803	110,857	100,343	75,199	68,796	53,825	41,607
Depreciation And Amortization	144,733	85,872	117,100	71,231	57,975	41,630	42,067	38,771	24,084	21,754	19,397	18,108	16,949	15,196	13,502
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Ebit	256,299	227,951	171,953	111,433	171,989	184,443	170,398	164,105	149,686	149,696	147,783	113,221	100,302	93,259	85,683
Ebitda	401,032	313,823	289,053	182,664	229,964	226,073	212,465	202,876	173,770	171,450	167,180	131,329	117,251	108,455	99,185
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Extraordinary Items	0	0	0	0	0	0	-11,000	0	0	0	0	0	0	0	0
Gross Profit	1,020,302	759,118	718,879	571,579	605,393	553,559	485,524	429,289	411,950	363,514	334,116	310,795	262,682	234,370	212,737
Income Before Tax	165,393	243,019	180,407	125,899	189,946	188,605	169,928	157,279	172,805	138,642	102,001	114,653	96,949	87,739	81,778
Income Tax Expense	42,520	52,850	31,216	23,614	34,736	32,131	62,580	52,938	60,021	46,157	33,389	40,822	36,165	33,281	29,745
Interest Expense	20,130	14,233	9,297	13,952	17,406	13,278	6,608	3,057	1,304	805	0	0	0	0	0
Interest Income	0	0	0	0	17,481	13,638	7,517	2,575	145	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	122,873	190,169	149,191	102,285	155,210	156,474	107,348	104,341	112,784	92,485	68,612	73,831	60,784	54,458	48,733
Net Income Applicable To Common Shares	0	190,169	149,191	102,285	155,210	156,474	107,348	104,341	112,784	92,485	68,612	73,831	60,784	54,458	0
Net Income From Continuing Ops	122,873	190,169	149,191	102,285	155,210	156,474	107,348	104,341	112,784	92,485	68,612	73,831	0	0	0
Net Interest Income	20,130	14,233	9,297	13,952	17,406	13,278	6,608	3,057	0	0	0	0	0	0	0
Non Operating Income Net Other	0	15,068	8,454	14,466	0	19,280	8,088	3,138	583	280	328	-140	0	0	0
Non Recurring	0	8,300	22,905	4,039	0	7,559	4,279	4,982	-11,268	5,667	23,055	-786	0	0	0
Operating Income	133,142	227,951	171,953	111,433	171,989	169,325	161,840	154,141	172,222	138,362	101,673	114,793	97,362	87,685	81,905
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Operating Expenses	1,366,626	786,592	763,244	673,570	608,614	536,085	469,858	404,871	383,799	330,342	309,731	271,987	232,646	197,723	170,550
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reconciled Depreciation	144,733	68,252	69,867	62,874	52,734	41,630	42,067	0	0	0	0	0	0	0	0
Research Development	124,010	73,015	97,346	84,519	60,073	55,496	43,679	44,532	36,982	31,687	26,870	27,926	23,464	21,309	20,521
Selling And Marketing Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Selling General Administrative	643,410	432,117	408,149	354,757	354,757	311,591	267,817	222,156	214,014	187,798	182,518	168,862	163,929	143,898	0
Tax Provision	42,520	52,850	31,216	23,614	34,736	32,131	62,580	52,938	60,021	0	0	0	0	0	0
Total Operating Expenses	818,452	522,867	524,021	456,107	428,639	376,675	319,405	270,166	250,996	219,485	209,388	196,788	163,850	143,898	128,943
Total Other Income Expense Net	165,393	15,068	8,454	14,466	17,957	11,721	3,809	-1,844	11,851	-5,387	-22,727	646	-1,883	-2,733	-2,016
Total Revenue	1,568,476	1,022,843	958,102	789,042	785,368	712,969	635,977	563,994	544,753	474,371	434,459	385,994	331,478	288,195	254,344

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31
Cost Of Revenue	265,486	135,390	76,473	70,825	70,591	65,497	68,470	59,167	61,796	58,554	63,846	55,027	60,859	57,097	50,643	48,864	48,760	45,387	43,990	41,838	45,954	37,849	37,637	37,970	40,856	36,798	37,199	35,600	39,002	31,453	32,856	31,644	35,065	33,052	32,579	32,107	31,276	27,686	26,583	25,312	26,774	25,315	24,761	23,493	19,557	18,872	18,379	18,391	19,487	17,141	17,269	14,899	38,629
Depreciation And Amortization	71,162	13,761	18,075	20,618	17,400	18,484	15,826	21,758	4,556	16,751	19,130	17,157	16,904	4,152	15,101	14,568	3,397	13,575	12,859	12,254	3,063	10,461	2,178	9,476	2,238	10,838	1,809	12,240	17,235	7,838	7,022	6,676	6,415	6,090	5,905	5,674	5,697	5,373	5,387	5,297	5,186	4,859	4,742	4,610	4,608	4,612	4,507	4,381	4,747	4,326	4,055	3,821	0
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Ebit	21,877	102,816	72,694	56,403	54,028	59,702	67,776	46,445	34,428	56,163	73,407	55,188	61,958	52,709	-24,889	30,012	51,942	46,284	42,992	37,882	55,791	39,039	43,703	46,029	48,778	38,756	39,091	40,836	36,880	40,034	44,030	42,851	32,595	40,729	31,873	38,604	43,180	35,015	34,189	37,312	41,021	29,701	47,730	29,331	24,532	27,105	30,869	28,447	26,459	26,701	23,834	23,336	0
Ebitda	93,039	116,577	90,769	77,021	71,428	78,186	83,602	68,203	38,984	72,914	92,537	72,345	78,862	56,861	-9,788	44,580	55,339	59,859	55,851	50,136	58,854	49,500	45,881	55,505	51,016	49,594	40,900	53,076	54,115	47,872	51,052	49,527	39,010	46,819	37,778	44,278	48,877	40,388	39,576	42,609	46,207	34,560	52,472	33,941	29,140	31,717	35,376	32,828	31,206	31,027	27,889	27,157	0
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Extraordinary Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit	351,048	248,249	215,142	205,863	203,907	188,651	195,178	171,382	188,225	171,167	187,170	172,317	172,586	159,001	98,279	141,713	162,907	150,828	150,549	141,109	149,984	131,387	135,747	136,441	135,178	114,946	115,191	120,209	112,588	104,198	104,633	107,620	107,522	103,940	100,991	99,497	97,525	90,101	86,990	88,898	88,471	81,872	82,248	81,525	80,979	75,892	77,598	76,326	68,506	67,129	63,667	63,380	249,566
Income Before Tax	24,995	2,535	74,674	63,189	62,116	61,465	70,540	48,898	19,828	54,452	48,933	57,194	62,213	53,130	-21,942	32,498	54,450	46,752	47,093	41,651	47,627	42,597	50,304	48,077	50,600	37,357	39,557	42,414	36,477	38,855	38,336	43,611	56,233	40,928	37,471	38,173	39,478	34,799	31,878	32,487	31,820	29,700	10,971	29,510	29,094	27,015	30,261	28,283	23,492	26,357	23,784	23,316	87,739
Income Tax Expense	9,960	1,537	16,962	14,060	12,051	14,034	15,950	10,814	4,722	7,241	7,388	11,865	9,256	8,914	-1,105	6,549	8,920	8,445	8,930	8,441	10,876	7,389	5,327	8,539	26,224	11,766	10,890	13,700	12,179	12,628	12,530	15,601	18,632	14,447	13,417	13,525	11,840	11,738	11,231	11,348	10,835	9,390	3,545	9,619	8,327	10,528	11,260	10,707	9,922	9,494	7,864	8,885	33,281
Interest Expense	2,581	7,920	8,294	6,497	5,315	3,899	2,476	2,543	1,939	2,105	2,541	2,712	18,276	3,085	3,590	4,324	4,452	4,377	4,417	4,159	4,164	3,852	2,971	2,291	1,862	1,738	1,590	1,418	1,164	795	602	496	406	342	278	278	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3,856	4,404	4,522	4,207	4,348	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	15,034	998	57,712	49,129	50,065	47,431	54,590	38,084	15,106	47,211	41,545	45,329	52,957	44,216	-20,837	25,949	45,530	38,307	38,163	33,210	36,751	35,208	44,977	39,538	24,376	25,591	28,667	28,714	24,298	26,227	25,806	28,010	37,601	26,481	24,054	24,648	27,638	23,061	20,647	21,139	20,985	20,310	7,426	19,891	20,767	16,487	19,001	17,576	13,570	16,863	15,920	14,431	54,458
Net Income Applicable To Common Shares	0	998	57,712	49,129	50,064	47,431	54,590	38,084	15,106	47,211	41,545	45,329	52,957	44,216	-20,837	25,949	45,529	38,307	38,163	33,210	36,751	35,208	44,977	39,538	24,376	25,591	28,667	28,714	24,298	26,227	25,806	28,010	37,601	26,481	24,054	24,648	27,638	23,061	20,647	21,139	20,985	20,310	7,426	19,891	20,767	16,487	19,001	17,576	13,570	16,863	15,920	14,431	54,458
Net Income From Continuing Ops	15,034	998	57,712	49,129	50,064	47,431	54,590	38,084	15,106	47,211	41,545	45,329	52,957	44,216	-20,837	25,949	45,529	38,307	38,163	33,210	36,751	35,208	44,977	39,538	24,376	25,591	28,667	28,714	24,298	26,227	25,806	28,010	37,601	26,481	24,054	24,648	27,638	23,061	20,647	21,139	20,985	20,310	7,426	19,891	0	16,487	19,001	0	0	0	0	0	0
Net Interest Income	-2,581	7,920	8,294	6,497	5,315	3,899	2,476	2,543	1,939	2,105	2,541	2,712	2,953	3,085	3,590	4,324	4,452	4,377	4,417	4,159	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Operating Income Net Other	0	0	8,462	6,786	8,088	1,763	2,764	2,453	1,628	1,123	3,057	2,646	3,678	3,117	3,621	4,050	0	4,691	4,224	4,572	4,375	4,296	8,165	2,444	2,240	1,562	2,186	2,100	755	1,205	418	760	236	253	441	-347	-166	-124	325	245	73	197	-221	279	0	-45	-304	0	0	0	0	0	0
Non Recurring	0	0	2,967	1,361	7,791	-652	-1,104	2,265	7,887	968	13,870	180	1,975	1,263	253	548	0	559	106	579	6,271	268	782	238	209	2,822	860	388	734	1,192	3,056	0	-11,701	27	374	32	1,768	46	1,318	2,535	4,637	99	18,269	50	0	30	-1,138	0	0	0	0	0	0
Operating Income	10,123	404	66,212	56,403	54,028	59,702	67,776	46,445	18,200	53,329	45,876	54,548	58,535	50,013	-25,563	28,448	49,980	42,061	42,869	37,079	43,251	38,301	42,139	45,633	48,360	35,795	37,371	40,314	35,722	37,650	37,918	42,851	55,997	40,675	37,030	38,520	39,644	34,923	31,553	32,242	31,747	29,503	11,192	29,231	29,110	27,060	30,565	28,058	23,712	26,529	23,809	23,312	90,472
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Operating Expenses	590,579	334,686	222,436	218,924	212,679	195,098	196,976	181,839	223,934	175,424	191,270	172,616	172,935	164,822	174,232	161,581	159,791	151,970	151,564	145,289	146,417	130,667	130,463	128,540	127,465	113,127	114,159	115,107	115,289	96,809	96,515	96,413	98,291	96,290	96,166	93,052	87,389	82,818	80,702	79,433	78,861	77,585	77,548	75,737	71,411	67,704	65,412	66,352	62,811	57,741	57,127	54,953	0
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reconciled Depreciation	71,162	13,761	18,075	18,108	16,910	17,578	16,927	16,837	16,829	16,751	19,130	17,157	16,904	16,301	15,101	14,568	14,046	13,575	12,859	12,254	11,936	10,461	9,757	9,476	8,294	10,838	10,695	12,240	17,235	7,838	7,022	6,676	6,415	6,090	5,905	5,674	5,697	5,373	5,387	5,297	5,186	4,859	4,742	4,610	4,608	4,612	4,507	4,381	4,747	4,326	4,055	3,821	0
Research Development	52,253	29,329	21,347	21,082	19,507	18,701	17,395	17,412	51,022	15,853	15,547	14,924	15,241	14,421	39,455	15,402	15,496	14,508	15,746	14,324	13,758	15,527	13,523	12,689	11,413	10,887	10,713	10,666	13,643	10,265	11,251	10,199	9,836	9,409	9,081	8,656	8,404	8,146	7,694	7,443	6,418	6,568	7,037	6,847	7,228	7,022	6,940	6,736	5,773	5,916	5,735	6,040	21,309
Selling And Marketing Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Selling General Administrative	244,719	156,206	120,069	122,416	118,075	106,576	106,718	100,748	106,560	96,444	107,254	97,891	92,047	89,152	80,019	93,539	92,139	88,455	88,379	85,784	83,642	75,131	77,125	75,694	72,958	63,362	64,438	67,059	60,839	54,207	52,408	54,570	53,390	53,829	54,506	52,289	47,709	46,986	46,425	46,678	45,669	45,702	45,750	45,397	44,626	41,780	41,231	48,063	43,891	40,648	39,336	40,054	143,898
Tax Provision	9,960	1,537	16,962	14,060	12,051	14,034	15,950	10,814	4,722	7,241	7,388	11,865	9,256	8,914	-1,105	6,549	8,920	8,445	8,930	8,441	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Operating Expenses	325,094	199,296	145,963	148,099	142,088	129,601	128,506	122,672	162,138	116,870	127,424	117,589	112,076	107,725	123,589	112,717	111,031	106,583	107,574	103,451	100,463	92,818	92,826	90,570	86,609	76,329	76,960	79,507	76,287	65,356	63,659	64,769	63,226	63,238	63,587	60,945	56,113	55,132	54,119	54,121	52,087	52,270	52,787	52,244	51,854	48,832	47,033	47,961	43,324	40,600	39,858	40,054	0
Total Other Income Expense Net	24,995	-54,338	-2,799	6,786	8,088	1,763	2,764	2,453	-8,198	-1,950	-13,354	-246	-1,250	-1,231	-222	-822	-1,878	-1,870	-299	-166	-1,894	176	7,383	-85	2,031	-2,998	1,326	294	176	13	-2,638	760	11,937	226	67	-657	-1,934	-170	-993	-2,290	-4,564	98	-18,490	229	-31	-45	-304	-82	-1,690	-172	-25	-10	0
Total Revenue	616,534	383,639	291,615	276,688	274,498	254,148	263,648	230,549	250,021	229,721	251,016	227,344	233,445	216,098	148,922	190,577	211,667	196,215	194,539	182,947	195,938	169,236	173,384	174,411	176,034	151,744	152,390	155,809	151,590	135,651	137,489	139,264	142,587	136,992	133,570	131,604	128,801	117,787	113,573	114,210	115,245	107,187	107,009	105,018	100,536	94,764	95,977	94,717	87,993	84,270	80,936	78,279	288,195

Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue	1,568,476
Cost of Revenue	-548,174
Gross Profit	1,020,302	1,020,302

Operating Income (+$)
Gross Profit	1,020,302
Operating Expense	-818,452
Operating Income	133,142	201,850

Operating Expense (+$)
Research Development	124,010
Selling General Administrative	643,410
Selling And Marketing Expenses	0
Operating Expense	818,452	767,420

Net Interest Income (+$)
Interest Income	0
Interest Expense	-20,130
Other Finance Cost	-40,260
Net Interest Income	20,130

Pretax Income (+$)
Operating Income	133,142
Net Interest Income	20,130
Other Non-Operating Income Expenses	0
Income Before Tax (EBT)	165,393	-32,251 EBIT - interestExpense = 236,169 165,393 143,003
Interest Expense	20,130
Earnings Before Interest and Taxes (EBIT)	256,299	185,523
Earnings Before Interest and Taxes (EBITDA)	401,032

After tax Income (+$)
Income Before Tax	165,393
Tax Provision	-42,520
Net Income From Continuing Ops	122,873	122,873
Net Income	122,873
Net Income Applicable To Common Shares	0

Non-recurring Events
Discontinued Operations	0
Extraordinary Items	0
Effect of Accounting Charges	0
Other Items	0
Non Recurring	0
Other Operating Expenses	1,366,626
Total Other Income/Expenses Net	165,393	-20,130

Technical Analysis of Globus Medical
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Globus Medical. The general trend of Globus Medical is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Globus Medical's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitions	Bullish trend (-57.1%)		Bearish trend (57.1%)
Overbought to neutral	Bullish pullback	=	Bearish reversal
Upper to lower neutral	Bullish correction	=	Bearish continuation
Nuetral to oversold	Oversold	=	Oversold
Oversold to neutral	Bullish reversal	=	Bearish correction
Lower to upper neutral	Bullish continuation	=	Bearish pullback
Nuetral to overbought	Overbought	=	Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.

Score

Let's take a look at the Support & Resistance of Globus Medical.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 50.87 < 50.95 < 54.04.

The bearish price targets are: 47.53 > 44.02 > 43.39.

Tweet this

Globus Medical Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

Moving averages are lagging trend indicators.
There are many types of moving averages.
Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Globus Medical. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

MA 20 trending down: The MA 20 is trending down. -1
Close < MA 20: The price is below the MA 20. -1
MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
MA 50 trending down: The MA 50 is trending down. -1
Close < MA 50: The price is below the MA 50. -1
MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
MA 100 trending up: The MA 100 is trending up. +1
Close < MA 100: The price is below the MA 100. -1
MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
MA 200 trending down: The MA 200 is trending down. -1
Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving Average	Amount of candles	vs. MA 50	vs. MA 100	vs. MA 200
MA 20	20
MA 50	50	-
MA 100	100	-	-
MA 200	200	-	-	-

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shows the moving average of the selected period.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

There are various kinds of moving averages:

Simple moving average (SMA);
Exponential moving average (EMA);
Smoothed moving average (SMMA);
Linear weighted moving average (LWMA).

The moving average looks at a certain period of time and it calculates the price average. The various types of averages are using various formulas. Don’t worry, you don’t have to memorize any formula. All moving averages are calculated automatically by basically every charting software you use. But it’s good to know how moving averages are actually calculated.

Simple moving average

SMA is calculated by summing up the price closures of the selected period. The price is then divided by the selected period. For example, when using the 21 day moving average you sum up all the closing prices for each day and divide that by 21. The result is a line on the chart representing the average. Because it’s an average in the selected timeframe, the trend is always lagging. An moving average looks like this on the chart:

Source: Tradingview.com

In this case, the blue line represents a 21 day moving average. Because the average is based on results from the past, the indicator will always lag behind. For example, when price would suddenly go up, the moving average won't immediately follow.

All other moving averages discussed below look the same on the chart. The only difference is that the line will move in different directions based on the maths behind the used indicators and the amount of days used to determine the average.

Exponential moving average

The EMA gives more weight to the latest closing prices by giving them more value in the equation. EMA is calculated by adding a certain percentage to the latest closing prices:

EMA = (CLOSE (i) * P) + (EMA (i - 1) * (1 - P))

Where:

CLOSE (i) = current period close price.
EMA (i - 1) = value of the Moving Average of a preceding period.
P = the percentage of using the price value.

Smoothed moving average

A smoothed moving average is an exponential moving average with a long lookback period. Older prices are reduced in weight but are never left out in the calculation. Unlike SMA and EMA where prices are removed when they are beyond the selected period. SMMA is a combination of the SMA and EMA. The main advantage is that it smooths out fluctuations in price.

Linear weighted moving average

The LWMA gives the latest price the highest weight and then lineary scales down with each price before that. The result is that the LWMA reacts quicker to changes in price than the SMA or EMA. The formula:

LWMA = ((Pn∗W1)+(Pn−1∗W2)+(Pn−2∗W3)...) / ∑W

Where:

P = Price for the period.
n = The most recent period, n-1 is the prior period, and n-2 is two periods prior.
W = The assigned weight to each period, with the highest weight going first and then descending linearly based on the number of periods being used.

Moving averages are widely used by many traders. Which moving average you need depends on your trading strategy. Common practise is using a combination of multiple periods. For example, the EMA21, EMA50, EMA100 and EMA200. How does that look on a chart:

Source: Tradingview.com

The lowest (purple) line on the chart represents the EMA200 then following up the EMA100, EMA50 and EMA21.

You can use moving averages to determine a trend. The 200 moving average is mostly used as a baseline for determining the current trend:

When the 200 moving average is moving up it is considered a bullish trend.
When the 200 moving average is down it is considered a bearish trend.
When moving averages are flatlined, there is no clear trend so you should look for market structure, consolidation or trend reversals. Depending on how you want to trade.

This is not set in stone. Most trading strategies use multiple moving averages each with different settings. While one strategy might use the EMA20, the other uses the SMA21. There can be hundreds of different variations. Moving averages can also be used as support and resistance. More often than not, prices will bounce on moving averages.

Globus Medical Daily Moving Averages Chart

2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

MACD is a lagging momentum indicator.
Uses two moving averages.
Can show buy or sell signals based on momentum.
Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Globus Medical. The current macd is -0.56158094.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Globus Medical price going down in the near term. -2
MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Globus Medical. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Globus Medical price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1

Globus Medical Daily Moving Average Convergence/Divergence (MACD) Chart

2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.

Score

Let's take a look at the Directional Movement Index (DMI) of Globus Medical. The current adx is 11.11.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Globus Medical shares, leading to potential downward momentum in its price. -1
PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1

Globus Medical Daily Directional Movement Index (DMI) Chart

2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

Parabolic SAR (stop and reverse) is a lagging trend indicator.
Shows the current trend.
Shows potential entry signals.
Shows potential exit signals.
Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Globus Medical. The current sar is 53.89.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1

Globus Medical Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

Leading momentum indicator, meaning the signals are instant.
Ranges between 0 and 100.
Above 70 is considered overbought.
Below 30 is considered oversold.
Above or below 50 can also be used to determine price trend or support and resistance.
RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Globus Medical. The current rsi is 37.75. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Trending down: The RSI is trending down. -1

Measures the speed and change of price movements.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

The RSI measures the magnitude of recent price changes to determine if the asset is overbought or oversold.

Overbought (RSI above 70) means that the trading price is above its intrinsic value. This might indicate a sell or short signal.
Oversold (RSI below 30) means that the trading price is below its intrinsic value. This might indicate a buy or long signal.
RSI levels above or below 50 can also be used to determine a trend.
RSI divergence looks at a deviation between RSI and price movement.
Can be used in many different ways.

Original usage

Keep in mind that almost every indicator can be used in different ways. Even beyond the orginal settings. The relative strength index was developed by J. Welles Wilder. Wilder recommended a smoothing period of 14 days. That means a 14 day moving average (read more about this setting below). Another quote from the wikipedia page:

Wilders also considers the RSI 50 line as both support and resistance. I recommend to always read the original settings first before using an indicator. Many traders and websites are using their own version of the indicator which might be confusing.

How you can use RSI (Divergence)

First and foremost, there is no real right or wrong usage of the RSI indicator. You can use it in any way you want. Wilder recommends using a 14 day average but you can make it 50 or 100 if you like. Just keep in mind that using an indicator is just part of a larger trading plan. In other words, it’s not recommended to do any trading or investing based on a single indicator like the RSI.

The RSI is measured on a scale between 0 and 100. From 30 till 0 is considered oversold. and from 70 -100 is overbought. The RSI is a leading indicator, meaning the signals are instant.

I like to use the RSI as a trend\momentum indicator and not as an overbought or oversold indicator. I use the middle (50) as the baseline. When prices go above RSI 50 the trend is bullish and can indicate long positions. When below 50 it is considered bearish and can indicate short positions. Other traders use the 70 and 30 levels as overbought/oversold depending on the used strategy. The RSI indicator looks like this:

Source: Tradingview.com

The general concensus is that an RSI above 70 indicates that the security is overbought. In other words, the price this security is trading for is to high and should come down. So if RSI hits 70 or above this might indicate a sell signal or taking a short position (expecting the price will go down). Although RSI above 70 indicates the security is trading above it's fair value, that does not mean the price will go down.

Use tradingview to add indicators

I highly recommend using tradingview to add indicators to a chart. It has all the indicators you can think off and can add them for free (up to three indicators) to any chart you want. You can see that the levels 30 and 70 are marked with a dotted line. If you want you can remove these lines or give it another colour using Tradingview. You can also adjust the moving average used. You can also find RSI indicators made by the community that include other settings like RSI divergences.

Tradingview

Use Tradingview to (back)test your strategies and add hundreds of indicators created by the community.

View tool on Tradingview.com

RSI divergence

RSI is not only used to determine momentum but can also spot reversals or continuations of the trend. A reversal means that the trend is going in the opposite direction. From bullish to bearish or from bearish to bullish. These reversals can be spotted by looking at the price and the direction of the RSI. When the price is going up but the RSI is going down that means there is a divergence. This is also the case when RSI goes up but price is going down.

There are four types of divergences:

Regular bullish divergence
Regular bearish divergence
Hidden bullish divergence
Hidden bearish divergence

Regular bullish divergence

With a regular bullish divergence, the price is making lower highs but the oscillator (in this case the RSI) is making higher lows. A regular bullish divergence might indicate the end of the current trend. You’ll see regular bullish divergences mostly at the end of a downtrend. But that does not mean that every regular bullish divergence is a trend reversal.

Price is making lower highs
RSI is making higher lows
Indicating bullish reversal (price might go up)

Source: Tradingview.com

Regular bearish divergence

With a regular bearish divergence the price is making higher highs but the oscillator (in this case the RSI) is making lower highs. This might indicate the end of an uptrend.

Price is making higher highs
RSI is making lower highs
Indicating bearish reversal

Source: Tradingview.com

Hidden bullish divergence

With a hidden bullish divergence, the price is making a higher low while the RSI is making a lower low. This might indicate bullish trend continuation.

Price is making higher lows
RSI is making lower lows
Indicating bullish continuation

Source: Tradingview.com

As you have noticed, you can have multiple divergences in a row.

Hidden bearish divergence

With a hidden bearish divergence, price is making lower highs but RSI is making higher highs. This might indicate bearish trend continuation.

Price is making lower highs
RSI making higher highs
Indicating bearish continuation

Source: Tradingview.com

You can find many cheatsheets of RSI divergences online. Search for "RSI divergence overview" and you'll find a lot of examples. You can print these to learn the various types of divergences.

Globus Medical Daily Relative Strength Index (RSI) Chart

3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

Leading momentum indicator, meaning the signals are instant.
Used to determine overbought and oversold areas much like the RSI.
Ranges between 0 and 100.
Above 80 is considered overbought.
Below 20 is considered oversold.
Consists of two lines named K and D.
K compares the highest high and lowest low on the selected price range.
The D line is a moving average of the K line.
Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Globus Medical. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
STOCH < 20: The STOCH %K is below 20 and oversold. -2
STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Globus Medical price going up in the near term. +2
Trending up: The STOCH %K is trending up. +1

Globus Medical Daily Stochastic Oscillator Chart

3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

Lagging or leading Momentum indicator
When the CCI is above zero, the price is above the historical average
When the CCI is below zero, the price is below the historical average
Used for spotting trends
- If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
- If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Globus Medical. The current cci is -146.24948796.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1

Globus Medical Daily Commodity Channel Index (CCI) Chart

3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

Lagging momentum indicator
Ranges between +100 and -100
Considered overbought above +50
Considered oversold below -50
It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Globus Medical. The current cmo is -34.8470448.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1

Globus Medical Daily Chande Momentum Oscillator (CMO) Chart

3.5 Williams %R

Shows the current price relative to the highest high over the last 14 days.

Lagging momentum indicator
Ranging between 0 and -100
Above -20 is considered overbought
Below -80 is considered oversold
Is prone to give false signals

Score

Let's take a look at the Williams %R of Globus Medical. The current willr is -90.28436019.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

Lagging volatility indicator
Uses 3 bands: one upper, one lower and one in the middle
Works best when the middle band reflects an intermediate trend (MA20).
When the price is moving closer to the upper band, the market might be overbought
When the price is moving closer to the lower band, the market might be oversold

Score

Let's take a look at the Bollinger Bands of Globus Medical.

Globus Medical Daily Bollinger Bands Chart

4.2 Average True Range (ATR)

Measures market volatility

Leading volatility indicator
Can be used to determine stop-loss positions
Calculated by:
- Current high minus the current low
- Current high minus the previous close
- Current low minus the previous close
The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Globus Medical. The current atr is 1.32458793.

Globus Medical Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Measures market volatility

Leading momentum indicator
Calculation:
- If the closing price is above the previous closing price: OBV = previous OBV + current volume
- If the closing price is below the previous closing price: OBV = previous OBV - current volume
- If the closing price is the same as the previous closing price than the OBV is the same.
Can be used to confirm price trends
Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Globus Medical. The current obv is -39,163,883.

Globus Medical Daily On-Balance Volume (OBV) Chart

5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

Lagging momentum indicator
Looks like RSI but uses volume as an extra metric (RSI only considers price)
Above 80 is considered overbought
Below 20 is considered oversold
Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Globus Medical. The current mfi is 30.14.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

MFI < 50: -1

Globus Medical Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

Type	Notification	Date
Currently no notifications for Globus Medical.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

Date	Indicator	Signal
2023-11-30	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-01	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2023-12-04	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2023-12-05	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2023-12-06	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2023-12-07	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-08	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2023-12-11	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
2023-12-12	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
2023-12-13	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2023-12-14	STOCH	LONG EXIT		The %K line crosses below the %D line.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2023-12-15	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2023-12-18	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
2023-12-20	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-21	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2023-12-22	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-26	MFI	LONG ENTRY	SHORT CLOSE	80 crossover to upside
2023-12-27	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
	MFI	SHORT ENTRY	LONG CLOSE	80 crossover to downside
2023-12-28	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-29	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-03	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
2024-01-05	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-09	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
2024-01-10	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-01-11	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-01-12	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-01-16	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
2024-01-18	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
2024-01-19	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-01-22	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-23	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
2024-01-24	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-01-29	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-01-30	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-01-31	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-01	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-02-08	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-12	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-15	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-02-16	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-02-20	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
2024-02-21	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
2024-02-23	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-02-26	STOCH	LONG EXIT		The %K line crosses below the %D line.
	MFI	LONG ENTRY	SHORT CLOSE	80 crossover to upside
2024-02-28	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-02-29	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	MFI	SHORT ENTRY	LONG CLOSE	80 crossover to downside
2024-03-01	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-03-05	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-03-06	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-03-07	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-03-08	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-03-12	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-13	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-14	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-03-18	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-25	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-03-26	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-27	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-03-28	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
2024-04-01	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-02	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-04-03	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-04	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-04-05	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-08	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-04-09	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-04-10	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-11	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-04-12	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-15	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-16	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-17	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-04-18	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-04-19	STOCH	SHORT EXIT		The %K line crosses above the %D line.

6.3. Candlestick Patterns

Date	Candlestick Pattern

6.4. Technical Score

Let's check the technical score of Globus Medical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	37.748
Ma 20	Greater than	Ma 50	52.092
Ma 50	Greater than	Ma 100	53.138
Ma 100	Greater than	Ma 200	52.360
Open	Greater than	Close	51.030
Total			2/5 (40.0%)

Create your own Symbol Scanner

Get notifications about Globus Medical

I send you an email if I find something interesting about Globus Medical.

Globus Medical Buy, Hold or Sell?

Let's analyse Globus Medical together

Get notifications about Globus Medical

Quick analysis of Globus Medical (30 sec.)

What can you expect buying and holding a share of Globus Medical? (30 sec.)

How much money do you get?

What is your share worth?

+ What do you gain per year?

For what price can you sell your share?

1. Valuation of Globus Medical (5 min.)

$50.35

$28.76

$8.10 - $17.86

$36.86 - $46.61

2. Growth of Globus Medical (5 min.)

Is Globus Medical growing?

How much money is Globus Medical making?

How much money comes from the company's main activities?

3. Financial Health of Globus Medical (5 min.)

4. Comparing to competitors in the Medical Devices industry (5 min.)

Industry Rankings (Medical Devices)

What can you expect buying and holding a share of Globus Medical? (5 min.)

What can you expect buying and holding a share of Globus Medical?

Speculation

Investing

How much money are you going to get?

When do you get the money?

How sure are you?

Linear %

Fundamentals of Globus Medical

About Globus Medical

Financial Health

Valuation

1.1. Profitability of Globus Medical.

1.1. Profitability

1.1.1. Net Profit Margin

Trends

Compared to industry (Medical Devices)

1.1.2. Return on Assets

Trends

Compared to industry (Medical Devices)

1.1.3. Return on Equity

Trends

Compared to industry (Medical Devices)

1.2. Operating Efficiency of Globus Medical.

1.2. Operating Efficiency

1.2.1. Operating Margin

Trends

Compared to industry (Medical Devices)

1.2.2. Operating Ratio

Trends

Compared to industry (Medical Devices)

1.3. Liquidity of Globus Medical.

1.3. Liquidity

1.3.1. Current Ratio

Trends

Compared to industry (Medical Devices)

1.3.2. Quick Ratio

Trends

Compared to industry (Medical Devices)

1.4. Solvency of Globus Medical.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Trends

Compared to industry (Medical Devices)

1.4.2. Debt to Equity Ratio

Trends

Compared to industry (Medical Devices)

2. Market Valuation of Globus Medical

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Trends

Compared to industry (Medical Devices)

Globus Medical
Buy, Hold or Sell?